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ABSTRACT 
 
Reproductive conditions and adverse birth outcomes disproportionately affect women in 
developing countries. Despite this fact, most research has been conducted with women in the 
United States and Europe. We sought to determine the burden and risk factors for reproductive 
outcomes among the 1,226 South Indian women in the Longitudinal Indian Family Health 
(LIFE) study. 
Bacterial vaginosis (BV) affected 14.1% (95% confidence interval (CI) 11.9-16.4%) of 
women in LIFE. When diagnosis by clue cells alone was compared to Nugent’s scoring, clue cell 
analysis had a sensitivity of 39.8% (95% CI 36.6-43.0%) and specificity of 81.2% (95% CI 78.6-
83.8%), with higher sensitivity among non-pregnant women (41.5%; 95% CI 37.8-45.2%) 
compared to pregnant women (29.4%; 95% CI 22.9-35.9%). Use of clue cells alone for diagnosis 
was found to be inadequate for screening women for BV and a validated method is 
recommended for future practice.  
We investigated several potential risk factors to determine their association with BV. In 
the model adjusted for religion and water source, Muslim women were more likely to have BV 
compared to Hindu women, though the increase was not significant (adjusted odds ratio (ORadj) 
1.8; 95% CI 0.9-3.6). Women using tap water were also more likely to have BV at baseline 
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compared to those who used purchased water (ORadj 1.4; 95% CI 0.9-2.0), though this increase 
was also not significant. These potentially at risk groups should be targeted for future screening 
programs. 
Consanguineous marriage (CM) occurs in up to 46% of South Indian marriages. Among 
women in CMs, we found a significant increase in the risk of early (<10 weeks’ gestation) 
spontaneous abortion (SAB) (adjusted hazards ratio (HRadj) 2.7, 95% CI 1.1-7.0). There was also 
a trend toward an increase in risk of late SAB (11-22 weeks’ gestation) (HRadj 1.2, 95% CI 0.4-
3.7) and all SAB (HRadj 1.9, 95% CI 0.9-3.8).  Women in CMs should be identified by health 
care providers and given counseling prior to conception and throughout pregnancy. 
This dissertation yields public health significance by identifying high-risk groups who 
should be targeted for screening and counseling programs by the clinics serving this rural South 
Indian population.  
 
 vi 
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1.0  SPECIFIC AIMS 
Adverse gynecologic and obstetric outcomes, including vaginal infections, spontaneous abortion, 
low-birth weight, intrauterine growth restriction, and preterm birth, account for a significant 
amount of maternal and infant morbidity worldwide.[1-3] This burden is disproportionally 
placed on developing countries. Despite this, few research studies have focused their efforts on 
identifying specific risk factors in these populations. The overall goal of this study is to 
determine the causes of adverse gynecologic and reproductive outcomes among women living in 
rural Andhra Pradesh, India.  
Bacterial vaginosis (BV) affects up to 39% of women in India. [4, 5] Transmission and 
risk factors for BV are poorly understood and may vary based on characteristics of the 
population being studied. Untreated, BV can lead to serious reproductive morbidity, including 
endometritis [6-9], cervicitis [8, 10-12], and pelvic inflammatory disease. [13-17] Among 
pregnant women, BV has been associated with spontaneous abortion, preterm birth, and low 
birth weight. [7, 11, 18-20] However, data on the association between BV and these outcomes is 
mixed. Proper screening tests for BV play a critical role in ensuring that women are diagnosed 
correctly and that treatment can be provided in a timely manner. 
Consanguineous marriages, especially among first cousins, are common in India. In the 
Indian state of Andhra Pradesh, population based surveys estimate the prevalence as 46%.[21] 
Consanguinity has been associated with increased risk of infant morbidity and mortality, 
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including excessive infant deaths, stillbirth, congenital malformations, and rare genetic 
conditions. [22-26] Studies of pregnancy outcomes from consanguineous marriage have largely 
been conducted in Middle Eastern countries and few investigations have focused on India. 
Outcomes may vary between populations based on the amount of genetic mixing and 
consanguinity.[27] This study aims to examine these risk factors in order to provide information 
to health care providers and researchers that will help to alleviate the heavy burden of adverse 
reproductive outcomes in rural Andhra Pradesh. 
The Longitudinal Indian Family Health (LIFE) Study is a longitudinal study in rural 
Andhra Pradesh, India, near the city of Hyderabad. Women and their husbands are recruited 
prior to conception or in the early weeks of pregnancy and followed through conception, 
pregnancy, delivery, and the postpartum period. Infants are followed through the first year of 
life. The focus of the study is to determine the risk factors leading to the high rates of adverse 
pregnancy outcomes, including spontaneous abortion, birth of a low birth weight or intrauterine 
growth restricted infant, preterm birth, and chorioamnionitis.  
A major innovation and strength of the LIFE study is that the Indian population studied 
attempts conceptions soon after marriage and has limited use of contraceptives. This allows us to 
enroll couples and measure risk factors pre-pregnancy. Due to limitations of identifying early 
pregnancies and biases involved in enrolling only women in a planning population, this study 
will provide a unique perspective and allow for testing of a variety of factors that have otherwise 
been unstudied. 
To this end, this dissertation seeks to achieve the following goals: 
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1. To determine the reliability of using clue cells as a test for bacterial vaginosis compared 
to using Nugent’s criteria. We hypothesize that using clue cells alone will have poor 
sensitivity and specificity compared to Nugent’s criteria.  
2. To determine the population-based prevalence of and risk factors for bacterial vaginosis 
in rural Andhra Pradesh. We hypothesize that women with BV at registration will be more 
likely to belong to a lower caste, report douching, report previous vaginal infections, 
report a recent urinary tract infection, and use tap water. 
3. To determine the association between consanguinity and spontaneous abortion in rural 
Andhra Pradesh. We hypothesize that women in consanguineous marriages will have an 
increased risk of spontaneous abortion.  
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2.0  BACKGROUND AND SIGNIFICANCE 
2.1 BACTERIAL VAGINOSIS 
Bacterial vaginosis (BV) is characterized by a change in the normal vaginal flora from a majority 
of lactobacilli to a mix of anaerobes, Gardnerella vaginalis, and Mycoplasma hominis.[28] In a 
healthy vagina, the lactobacilli are responsible for producing hydrogen peroxide (H2O2), which 
acts as an antimicrobial and prevents the overgrowth of other bacteria. [28] Among women of 
childbearing age, BV is the most common vaginal infection, with prevalence estimates ranging 
from 5% in extremely low-risk population [29] to 73% in high-risk populations recruited from 
sexually transmitted infection (STI) clinics. [30] In the general population, most studies have 
found a prevalence of about 20% to 40%.[31-34] Symptoms include abnormal vaginal discharge, 
abnormal odor, and burning or itching. The majority of women, up to 85%, do not report 
experiencing any of these symptoms. [35]  
The exact etiology of BV is currently unknown. While G. vaginalis was originally 
implicated as the organism responsible for this condition, later studies have shown that BV is a 
polymicrobial condition that has no one single causative agent. [28, 36, 37] G. vaginalis remains 
an important organism in the development and diagnosis of BV, with studies reporting that 50% 
to 100% of women with BV found to have G. vaginalis in their vaginal flora. [37-41] While the 
detection of G. vaginalis has been found to be 90% to 100% specific for diagnosis of BV, 
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specificity estimates range from 40% to 97%, with most studies showing numbers on the lower 
end. [37, 39-41] G. vaginalis is also found in up to 60% of women with normal and intermediate 
vaginal flora. [37, 39, 41] This evidence demonstrates the need for more research into the various 
organisms associated with the development of BV and the role each of them plays in determining 
outcomes. Unlike sexually transmitted infections (STIs), reproductive tract infections like BV 
are influenced by behavioral factors such as douching[42-44], smoking[45-47], and stress[48] 
and socio-demographic risk factors such as race[49-51] and social class. [50, 52] More research 
is needed to understand the transmission, development, and treatment of BV.  
BV is a serious women’s health concern as it has been associated with a number of 
adverse outcomes. Among non-pregnant women, BV has been associated with the development 
of pelvic inflammatory disease (PID) [13-17], cervicitis [8, 10-12], and infertility.[16, 53-55] BV 
infection may also make women more vulnerable to sexually transmitted infections, including 
Chlamydia, gonorrhea, and human immunodeficiency virus (HIV). [56-60] Among pregnant 
women, BV has been associated with an increased risk of spontaneous abortion (SAB), preterm 
birth (PTB), low birth weight (LBW), and chorioamnionitis. [7, 11, 18, 19] These adverse 
outcomes demonstrate the need for timely screening, diagnosis, and treatment of women with 
BV, in addition to identification and reduction of modifiable risk factors associated with 
infection. 
2.1.1 Diagnosis of BV 
2.1.1.1 Clinical Diagnostic Methods 
More than 80% of women with BV are asymptomatic. [32] Even among symptomatic patients, 
signs are nonspecific and easily confused with other vaginal infections. Symptoms include thin, 
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white or grey discharge with or without a fishy odor, burning during urination, and itching 
around the outside of the vagina. [61] Many women mistakenly self-diagnose as a yeast infection 
and treat with over-the-counter medications that are ineffective for the treatment of BV. In 
physician offices, diagnostic tests are used to differentiate BV from other common vaginal 
infections.  
In clinical practice Amsel's Criteria is most often used for diagnostic purposes. Diagnosis 
is made if a woman meets three of the four following criteria: 1) vaginal pH >4.5, 2) clue cells 
present on >20% of cells, 3) positive whiff test, and 4) abnormal discharge.[62] Though attempts 
have been made to develop an accurate screening tool such as a questionnaire or screening kit 
[63-65], that can be used by either the patient or a provider to ascertain BV without a full clinical 
evaluation, none have proven sensitive or specific enough for routine use. This presents an 
ongoing problem for diagnosis since many clinicians do not follow a full set of diagnostic 
criteria, which may result in up to 50% of cases being missed.[66] 
2.1.1.2 Standard Laboratory Methods 
In research, BV diagnosis is typically done through microscopic examination of a slide 
made from a vaginal swab. This method was first proposed in the early 1920s by Schöder, who 
identified three different grades of vaginal flora seen on a wet mount slide.[67] Grade I describes 
specimens showing numerous, normal lactobacillary morphotypes without other bacteria. Grade 
IIa describes specimens with mostly normal lactobacillary morphotypes, but where other bacteria 
are also seen. Grade IIb defines specimens where lactobacillary morphotypes are seen but are 
outnumbered by other coccid bacteria. Grade III is considered Grade III, where few to no 
lactobacillary morphotypes are seen and have been replaced by coarse, coccid bacterial or 
numerous parabasal epithelial cells. [68] This method was later rearticulated by Donders in a 
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paper comparing the Lactobacillary grades to diagnoses made using Amsel’s and Nugent’s 
methods. While a number of similarities exist, the Grades described above do not correspond 
directly to categories created by these other diagnostic systems.[68] Spiegel et al. described a 
similar method of diagnosis using Gram stain slides instead of wet mounts. Using a system of 
scoring, each morphotypes was quantified as 1+ when there was <1 morphotypes per field, 2+ 
where there was one to five per field, 3+ when there were six to 30 per field, and 4+ when more 
than 30 were present. [69] Based on this system, when only Lactobacillus morphotype was 
present (3 to 4+) or was present with only the Gardnerella morphotype (1 to 2+), the slide is 
interpreted as normal. When the flora is mixed and the Gardnerella morphotype and other 
bacteria where present and Lactobacillus was not present or only present in low numbers (1 to 
2+), the slide is classified as consistent with BV.[69] This system was later updated and modified 
by Hay et al. to include an intermediate category. Thus, the normal classification described 
above became Grade I, which described a flora made up of predominately Lactobacillus 
morphotypes. An intermediate level (Grade II) was added, describing those with reduced 
lactobacillus morphotypes mixed with other morphotypes. Finally, the category consistent with 
BV, termed grade III, was reserved for those with few or no lactobacillus and an increased 
number of Gardnerella morphotypes and/or other morphotype.[70] Currently, the scoring system 
described by Nugent et al. is considered to be the gold standard for diagnosis in research 
settings[71] This method involves examining Gram-stained slides for the presence and of three 
types of morphotypes: lactobacillus morphotypes, Gardnerella and Bacteroides spp. 
morphotypes, and Mobiluncus spp. morphotypes (Table 1). Overall scores of zero to three are 
considered normal, scores of four to six intermediate, and scores of seven to ten are considered to 
be consistent with BV.  
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The use of Nugent’s criteria for diagnosing BV has been examined extensively and found 
to have a high degree of sensitivity (89.1%) and specificity (83.1%) compared to Amsel’s 
clinical criteria.[72] In addition, studies have shown that the method has a high degree of inter-
reader reliability, with kappa scores ranging from 0.62 to 0.75, indicating a high level of 
agreement. [73-75] While extremely useful for diagnosing BV, Nugent’s criteria requires both a 
longer period of time from testing to diagnosis and trained lab staff capable of reading and 
scoring the slides properly.   
 
Table 1. Nugent’s scoring method for diagnosing BV 
Score Lactobacillus 
morphotypes 
Gardnerella and 
Bacteroides spp. 
morphotypes 
Curved gram-variable 
rods (Mobiluncus spp. 
morphotypes) 
0 >30 0 0 
1 5-30 <1 <1 
2 1-4 1-4 1-4 
3 <1 5-30 5-30 
4 0 >30 >30 
Normal: 0-3; Intermediate: 4-6; BV: 7-10 
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2.1.1.3 Use of Polymerase Chain Reaction 
BV is not well understood. In recent years, polymerase chain reaction (PCR) methods have been 
developed and used to study the fastidious and difficult to culture bacteria associated with BV. 
Since multiple microorganisms are involved in the development of BV, specific knowledge of 
individual organisms may help to identify women with infections that put them at higher risk of 
adverse outcomes. Colonization of the vagina by lactobacillus species is important for the 
prevention of BV as many of these species produce hydrogen peroxide which is detrimental to 
the growth of BV pathogens. A handful of studies have sought to investigate the predominate 
species of lactobacillus in healthy women. A study of 23 healthy Swedish women showed that 
the most commonly occurring species, in descending order of frequency, to be L. crispatus, L. 
gasseri, L. iners, and L. jensenii. [76]  These results are similar to what was previously reported 
by another group, who identified L. crispatus, L. iners, L. jensenii, and L. gasseri as the most 
common species in a group of American women. [77] One hypothesis for the differences in 
species found is based on previous research on the colonization of the intestinal tract by 
lactobacillus species which has shown great variety dependent on geographic location. A study 
of women in Nigeria showed similar results to the studies of white women, with the most 
common species of lactobacillus being L. iners, L. gasseri, L. plantarum, and L. crispatus. [78] 
Other possible explanations for the differences in species found among different groups of 
women may be related to testing variables, particularly for members of the L. acidophilus 
complex, where phenotypic criteria are unreliable. [76] 
Identifying the most common species of lactobacillus provides important information 
about the etiology of BV. This knowledge may be most beneficial when looking at adverse 
outcomes, including recurrent infection, preterm birth, and chorioamnionitis. Wilks and 
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colleagues found that different species of lactobacillus produce different amounts of hydrogen 
peroxide. [79] As this mechanism is what helps prevent the growth of BV-associated bacteria, 
those colonized with high H2O2 producing species may be less likely to develop BV or have 
recurring infections. This same study found that women who had vaginal colonies of L. jensenii 
and L. vaginalis, the two species with the highest levels of H2O2 production, had half the risk of 
preterm birth and/or chorioamnionitis compared to those colonized with other species. [79] 
PCR has also been used to identify the bacteria associated with BV infection. These 
methods are necessary and important because many species of bacteria associated with BV, such 
as Gardnerella and Mobiluncus, are also found in women with normal vaginal flora. [37] 
Specifically, the method has shed light on the polymicrobial nature of the condition. Studies have 
shown that while women without BV have a vaginal flora almost completely dominated by 
species of Lactobacillus, women with BV have a large variety of vaginal bacteria. Oakley et al. 
were able to observe 61 taxa among infected women; however, due to the limitations of 
identification, they estimate that the true number they identified is closer to 75 (95% CI 63-111). 
[80] Studies have demonstrated that certain bacteria found to be highly associated with BV may 
provide more specific and sensitive diagnoses than currently practice. Most useful, appear to be 
BVAB1, BVAB2, BVAB3, Gardnerella, Atopobium species, Eggerthella-like uncultured 
bacteria, Leptotrichia species, and Megaspherea α. [37] In particular, compared to Amsel’s 
criteria, BVAB2 provided 88.9% sensitivity and 95.7% specificity, Eggerthella-like uncultured 
bacteria provided 92.6% sensitivity and 91.3% specificity, and Leptotrichia species provided 
85.2% sensitivity and 95.7% specificity. When BVAB2 and Megaspherea α were combined, 
sensitivity was 100.0% and specificity 91.3%. [37] These values are in contrast to the normally 
cited Gardnerella, which was shown in this study to have 100.0% sensitivity but only 41.3% 
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specificity. [37] A second study by the same group found that detection of either a Megaspherea 
species of a Clostridiales bacteria had a sensitivity of 99% and specificity of 89% for compared 
to Amsel’s and 95.9% sensitivity and 93.7% specificity compared to Nugent criteria. [36] Again, 
G. vaginalis was shown to be highly specific compared to Amsel’s and Nugent, 96.3% and 
97.3% respectively, but not specific, 29.5% and 45.5%. [36] Another important finding from 
PCR is that while many fastidious bacteria, such as L. sanguinegens/amnionii, A. vaginae, and 
BVAB1, are associated with BV as defined by Amsel and Nugent; they were not associated with 
abnormal vaginal discharge. [81] These results indicate that certain organisms may be associated 
with specific symptoms. Importantly, this may provide a reason why many women remain 
asymptomatic.  
2.1.1.4 Diagnosis using Self-Collected Vaginal Swabs 
For many reasons, individuals may not be able to attend a clinic or hospital in order to be 
screened for BV. This is especially true in resource poor settings or rural areas where providers 
are few and far between. For the purposes of research studies, the use of self-collected vaginal 
swabs allows more women to be screened in a shorter period than would be allowed if a provider 
was required to collect each sample. While only a few studies have compared the ability of self-
collected vaginal swabs to diagnose BV compared to provider-collected vaginal swabs, the 
results are strikingly swayed toward their reliability.  
 In a study of 84 pregnant women from an obstetrics ward in South Africa, Sturm et al. 
found between 86% and 90% agreement in the results from self-collected tampon fluid and 
provider collected swabs for diagnosis of BV using Nugent criteria, depending on the 
observer.[82] Nelson et al. examined self- and provider-collected vaginal samples from forty-
three women presenting for a prenatal visit at less than twelve weeks' gestation at the Hospital of 
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the University of Pennsylvania. For the comparison of self- versus provider-collected swabs, 
they found strong validity for a dichotomous diagnosis, with a kappa value of 0.94 (p<0.001), 
and for the continuous Nugent score (r=0.83).[83] Tanksale et al. examined self- and provider-
collected vaginal swabs for BV by Nugent score among 75 pregnant, non-pregnant, and 
postpartum women attending an outpatient gynecology clinic in India and found high agreement, 
with a kappa of 0.98 (p<0.001).[84] Strauss et al., examined the concordance of BV status by 
Nugent score made from self- and provider-collected vaginal swab among 129 women 24 to 29 
weeks' gestation seeking care at a University of North Carolina Hospital. The authors found that, 
when compared to the provider-collected swab, the self-collected swab had a sensitivity of 77%, 
specificity of 97%, positive predictive value of 71%, negative predictive value of 97%, and a 
kappa of 0.71 (95% CI: 0.51-0.91). In addition, when compared across the three grade levels, 
there was substantial agreement between the self- and provider collected sample, with a weighted 
kappa of 0.82 (95% CI: 0.72-0.91).[85] Kashyap et al. examined self- and provider-collected 
samples for BV using Nugent scores for 50 women attending an outpatient gynecology clinic in 
India and found moderate agreement between the two collection methods (kappa=0.48). The 
ability of the self-collected sample to determine BV had a sensitivity of 70%, specificity of 97%, 
positive predictive value of 94% and a negative predictive value of 83%. Overall, the predictive 
value of the self-collected swab was 86%.[86]  
 Overall, these studies provide sufficient evidence that using self-collected vaginal swabs 
for the detection of BV by Nugent’s criteria is both accurate and sensitive. In situations where it 
is inconvenient or prohibitively expensive to have provider-collected samples, self-collected 
vaginal swabs are an appropriate substitution.  
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2.1.2 Treatment of BV 
A woman’s vaginal flora can differ greatly over a relatively short period of time.[87] In studies 
of spontaneous recovery, 13% to 50% of women went from BV by Nugent’s criteria to either 
abnormal or normal flora within a period of one month from original testing.[88, 89] While 
many women with BV recover spontaneously, treatment for all symptomatic women and 
asymptomatic non-pregnant women is recommended by the Centers for Disease Control and 
Prevention (CDC) in order to prevent complications.[90] Standard treatment regimens are 
typically very successful when used as directed with most courses showing cure rates of at least 
70%.[91, 92] However, many patients either fail to respond to treatment of suffer from frequent 
relapses. Studies have shown that up to 70% of patients have a recurring infection within a year 
of the initial treatment[91, 93], with most studies showing rates closer to 30%. [94-96] 
Alternative therapies are often recommended in these instances, as well as an assessment of 
possible behavioral modifications.[90]  
2.1.2.1 Among Non-Pregnant Women 
Based on an assessment of the woman’s preferences, allergies, and drug interactions, standard 
treatment involves a course of 500 mg of Metronidazole taken orally twice a day for seven days, 
use of five grams of 0.75% Metronidazole gel intravaginally once a day for five days, or use of 
five grams of 2% Clindamycin cream intravaginally for seven days. Other possible treatments 
include the use of one and two gram oral doses of Tinidazole and a shortened use of 100 mg 
Clindamycin ovules intravaginally for three days.[90]  
As previously stated, the above regimens are not always efficacious. Development of 
alternative treatment methods has yielded numerous hypotheses and potential drugs, but none 
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which have shown significant results. The research with the most potential relates to the use of 
probiotics as a way to cure BV. Since BV results from an overgrowth of bacteria following the 
loss of normally occurring Lactobacillus, it is hypothesized that the reintroduction of these 
morphotypes may improve treatment outcomes. Of the four major studies published to date, half 
have shown statistically significant results. [97-100] The first study examined the use of oral 
probiotics in addition to oral metronidazole and found an overall small, but statistically 
significant, odds of having a normal Nugent score following treatment for those receiving 
probiotics (OR: 0.09; 95% CI: 0.03-0.26).[97] Another study comparing the use of intravaginal 
probiotics to a placebo and found the intervention to group to be more likely to clear the 
infection than the control group (OR: 0.02; 95% CI: 0.00-0.47).[100]  
The remaining studies were unable to show significant results using intravaginal 
probiotic therapies. A study by Anukam et al., comparing intravaginal probiotics with 
metronidazole found a non-significant increase in the odds of having a normal Nugent score 
following the intervention treatment (OR: 0.27; 95% CI: 0.07-1.10).[98] Eriksson et al., 
compared the use of vaginal clindamycin with vaginal showed the opposite effect of other 
studies, with those in the placebo group being more likely to have normal Nugent scores than 
those in the experimental group (OR: 1.21; 95% 0.67-2.19).[99]  Overall, evidence supporting 
the use of probiotics is weak. Further research needs to be done to determine the best strains to 
introduce to the vaginal flora of individuals and determine the appropriate drug regimens to 
accompany their use.  
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2.1.2.2 Among Pregnant Women 
The United States Preventive Services Task Force (USPSTF) recommends against screening for 
BV among asymptomatic pregnant women, regardless of their risk for adverse pregnancy 
outcomes.[101] The main basis for their decision is that there is insufficient evidence that 
treatment of asymptomatic BV in pregnant women decreases the risk of outcomes such as 
preterm birth. Some evidence even points to the fact that the treatment itself may have serious 
consequences, greater than those caused by the infection. [102-107] 
 Multiple studies have been done to look at whether screening and treatment of BV during 
pregnancy reduced the risk of preterm delivery. The majority of these studies have found either 
no difference between the preterm birth rate among those randomized to treatment and control. A 
few studies have shown a significant increase in risk among those receiving treatment.  
The most commonly examined drug is vaginal clindamycin. In a study of single uterine 
pregnancies among women with no prior preterm births, 101 women who screened positive for 
BV by gram stain at approximately 12 weeks' gestation were randomized to receive either 
20mg/g clindamycin cream or a placebo for one week. Participants were rescreened one week 
after treatment and again at 30 weeks' gestation. A total of 10 women in the study had a preterm 
birth, 7 from the group treated with clindamycin (13.7%) and 3 from the group treated with a 
placebo (6.0%). Overall, the researchers found a non-significant increase in the risk of preterm 
birth among women who screen positive for BV and were treated compared to women who 
screen positive but received a placebo (OR: 2.1; 95% CI: 0.6-10.0). [102] In another study by 
Kekki et al., the authors looked at women who screened positive for BV by gram stain between 
10 and 17 weeks' gestation. A total of 375 women were randomized to receive either a two 
percent clindamycin phosphate vaginal cream or a placebo for seven days of treatment. 
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Participants were screened again for BV at one week after treatment and again between 30 to 36 
weeks' gestation. Overall, the authors found that nine women in the treatment group (5%) and 
seven women in the placebo group (4%) had a preterm birth. Again, the authors found that 
women who screen positive for BV who received treatment had a non-significant increase in 
their risk of preterm birth compared to women who screened positive and received a placebo 
(OR: 1.3; 95% CI: 0.5-3.5). [103] In a study by Joesoef et al., a total of 745 women who 
screened positive for BV, defined as a Nugent score indicative of BV and a pH level greater than 
4.5, at 14 to 26 weeks’ gestation were randomized to either receive 5gm of 2% clindamycin 
vaginal cream for one week or a placebo. Overall, no difference was seen in the rate of preterm 
birth at <37 weeks’ gestation between the treatment (15%) and placebo groups (13.5%) (OR: 1.1; 
95% CI 0.7-1.7). A non-significant increase in preterm birth at less than 32 weeks’ gestation was 
seen among those who received clindamycin (4.7%) compared to those who received a placebo 
(2.6%) (OR: 1.8; 95% CI: 0.8-4.2). [104] In a study by Lamont et al., 409 women screened for 
positive BV or intermediate flora using Nugent’s method at less than 22 were randomized to 
receive either five grams of 2% clindamycin intravaginal cream for three days or a placebo. 
Women were rescreened 20 to 24 days after initial assessment and given a seven day course of 
the same treatment if they were positive for BV. Overall, the authors found a significant 
reduction in the occurrence of preterm birth among women who received clindamycin vaginal 
cream (4%) compared to the women who received a placebo (10%) (p=0.03). [105] An important 
component of this study was that nearly all women were treated before 20 weeks’ gestation and 
high percentage (60%) were treated prior to 16 weeks’ gestation. Though the authors were 
unable to show any statistically significant difference in the effect of gestational age at treatment 
on the outcome, this early treatment time may be the reason why the results from this study 
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contradict those of most other trials. In a study by Guaschino et al. the authors used a modified 
version of Spiegel’s method to screen women for BV between 14 and 25 weeks’ gestation. A 
total of 112 women who were found to be positive were randomized to receive either intra-
vaginal clindamycin 2% cream once a day for seven days or no treatment. Overall, the authors 
say no difference in the rate of preterm birth between women who screened positive who 
received clindamycin (12.2%) and women who received no treatment (15.7%) (p=0.78). The 
authors also saw no difference in the rate of premature rupture of membranes (PROM) (p=0.19) 
or low birth weight (p=0.32) between the two groups. [106] In a study by Kiss et al. 4155 women 
were screened for BV using Nugent criteria between 15 and 20 weeks’ gestation. For women in 
the intervention group, the results of this screening were shared with their provider. For women 
in the control group, both the participant and physician remained blinded to the outcome of the 
screening. For those in the intervention group who screened positive, treatment consisted of six 
days of intra-vaginal 2% clindamycin. If a recurrent or persistent infection was discovered, they 
were treated with 300mg oral clindamycin twice a day for seven days. Overall, 3% of the 
intervention group and 5.3% of the control group had a preterm birth (p=0.0001). Among women 
who screened positive for BV, six women in the intervention group and 10 in the control group 
had a preterm birth (no p-value provided). [107] In a study by Larsson et al. 819 women 
screening positive for BV by Nugent criteria between 10 and 14 weeks’ gestation were 
randomized to receive either a seven day dose of clindamycin vaginal cream or to remain 
untreated. There was a non-significant increase in the rate of preterm birth between the 
intervention group (5.1%) and the control group (6.1%) (OR: 0.84; 95% CI: 0.48-1.47). When 
the authors looked at spontaneous preterm births and late miscarriages together, there was a non-
significant increase in the risk among the control group (3.1%) compared to the clindamycin 
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group (2.8%) (OR 0.90; 95% CI 0.40-2.02). Interestingly, there was a significant difference in 
the mean gestation length at delivery between the intervention group (247.6 days) compared to 
the control group (215.0 days) (p=0.024). [108] In summary, only two of the seven clinical trials 
conducted using either oral or vaginal clindamycin have found a significant decrease in preterm 
birth following treatment (Table 2).  
 
Table 2. Randomized controlled trials on clindamycin treatment of BV in pregnancy 
Author 
(Year) 
N Time of 
BV 
Diagnosis 
Treatment Method Comparison 
Group 
Odds Ratio 
(95% confidence 
interval) 
Kurkinen-
Raty (2000) 
101 12 weeks' 20mg/g clindamycin for 7 
days 
Placebo 2.1 (0.6-10.0) 
Kekki 
(2001) 
375 10-17 
weeks' 
2% clindamycin vaginal 
cream for7 days 
Placebo 1.3 (0.5-3.5) 
Joesoef 
(1995) 
745 14-26 
weeks' 
2% clindamycin vaginal 
cream for 7 days 
Placebo 1.1 (0.7-1.7) 
Lamont 
(2003) 
409 <22 
weeks' 
2% clindamycin vaginal 
cream for 3 days + 7 
additional days of 
treatment for persistent 
infection 
Placebo 4% (treatment) 
vs. 10% 
(placebo) 
(p<0.03)a 
Guaschino 
(2003) 
112 14-25 
weeks' 
2% clindamycin vaginal 
cream for 7days 
No treatment 12.2% 
(treatment) vs. 
15.7% (control) 
(p=0.78)a 
Kiss (2004) 4,155 15-20 
weeks' 
2% clindamycin vaginal 
cream for 6 days +300mg 
oral clindamycin twice 
daily for 7 days if 
persistent infection 
No treatment 
b 
3% (treatment) 
vs. 5.3% 
(control) 
(p<0.0001)a 
Larsson 
(2006) 
819 10-14 
weeks' 
2% clindamycin vaginal 
cream for 7 days 
No treatment Preterm birth: 
0.84 (0.48-1.47) 
a OR and 95% CI not calculated 
b BV status was not disclosed to physicians, but symptomatic patients may have been treated 
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Another commonly investigated treatment option is oral metronidazole. In a study among 
low risk women was performed by Odendaal et al. who examined 150 primigravidae women and 
127 multigravidae women who screened positive for BV by Amsel's criteria at less than 26 
weeks' gestation. Women in both groups were randomized to receive either 400mg of 
metronidazole twice a day for two days or 100mg of Vitamin C twice daily for two days. Patients 
were rescreened for BV four weeks after receiving initial treatment. Those who screened positive 
were given another course of the same medication as they received the first time. Overall, the 
authors showed a non-significant increase of preterm birth from 16% among primigravidae 
women who received Vitamin C to18% among those received metronidazole. Among the 
multigravidae women, there was a significant increase (p=0.0274) in the rate of preterm birth 
from 24% of those who received Vitamin C to 43% among those who received metronidazole. 
[109] In a randomized trial by McDonald et al. the authors randomized women who screened 
positive for BV and had a heavy growth of G. vaginalis  at their 18 week prenatal visit a total of 
857 women to either 400mg of metronidazole twice daily for two days or a placebo. Women 
were rescreened at 28 weeks’ and those who screened positive were given a second course of 
their allocated treatment. Overall, the authors showed a non-significant decrease in the risk of 
preterm birth among those who received metronidazole (4.7%) compared to those receiving a 
placebo (5.6%) (OR: 0.82; 95% CI: 0.43-1.57). The same non-significant trend was seen whether 
the authors looked at intention to treat or only at those who actually received the allocated 
treatment. [110] In a third study done by Carey et al., a total of 1,953 women who had both a 
Nugent score greater or equal to seven and a vaginal pH level of greater than 4.4 when screened 
before 23 weeks’ gestation. These women were then randomized to either receive either two 
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doses of 2g metronidazole or a placebo administered before 24 weeks’ gestation. A second round 
of treatment was administered between 24 and 30 weeks’ gestation, at least two weeks after the 
first course. The authors found that the rate of preterm delivery did not differ between the 
treatment (12.2%) and the control (12.5%) groups (RR 1.0; 95% CI: 0.8-1.2). Similarly, no 
differences was noted when the authors examined risk of delivery before 35 weeks’ (RR: 1.0; 
95% CI: 0.7-1.5) and before 32 weeks’ (RR: 0.9; 95% CI 0.5-1.5). [111] Hauth et al., 
randomized 624 women who tested positive for BV by Amsel's criteria at a mean gestational age 
of 22.9 weeks' gestation to receive either a placebo or a combination of 250mg of metronidazole 
three times a day for seven days plus 333mg erythromycin three times a day for 14 days. Among 
those receiving treatment, 26% delivered a preterm infant compared to 36% of the placebo group 
(OR: 1.4; 95% CI 1.1-1.8). [112] Finally, a study by Morales et al. randomized 80 women with a 
history of preterm birth who screened positive for BV at 13 to 20 weeks' gestation by Amsel's 
criteria to either a placebo or 250mg of oral metronidazole three times a day for seven days. 
Overall, the investigators saw a significantly lower rate of preterm birth among those in the 
treatment group (18%) versus those in the control group (37%). [113] In summary, studies of 
metronidazole as treatment for BV during pregnancy have largely shown non-significant results. 
Some of the information seems to indicate that women receiving treatment may even be at an 
increased risk of preterm birth (Table 3). 
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Table 3. Randomized controlled trials on metronidazole treatment of BV in pregnancy 
Author 
(Year) 
N Time of 
BV 
Diagnosis  
Treatment Method Comparison 
Group 
OR (95% CI  ) 
Odendaal 
(2002) 
277  <26 
weeks' 
400mg metronidazole 
2x/day for 2 days + 2 
additional days for 
persistent infection 
100mg 
Vitamin C 
twice daily for 
two days 
Primigravidae: 18% 
(treatment) vs. 16% 
(control) (NS)a 
Multigravidae: 43% 
(treatment) vs. 24% 
(control) 
(p=0.0274)b 
McDonald 
(1997) 
857 18 weeks' 400mg oral 
metronidazole 2x/day 
for 2 days + repeat 
treatment for 
persistent infection 
Placebo 0.82 (0.43-1.57) 
Carey 
(2000) 
1953 <23 
weeks' 
Two doses 2g vaginal 
metronidazole + 
repeat treatment two 
weeks later 
Placebo 1.0 (0.8-1.2) 
Hauth 
(1995) 
624 22.9  
weeks' a  
250 mg oral 
metronidazole 3x/day  
for 7 days + 333mg 
erythromycin 3x/day 
for 14 days 
Placebo 1.14(1.1-1.8) 
Morales 
(1994) 
80 13-20 
weeks' 
250mg oral 
metronidazole 3x/day 
for 7 days 
Placebo 18% (treatment) vs. 
37% (control)b, d 
a No p-value provided, not significant 
b Odds ratio and 95% CI not calculated 
c Mean gestational age at enrollment 
d No p-value provided, significant 
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While most of the studies (n=13) done have not been able to demonstrate any 
improvement in preterm birth rates with clindamycin or metronidazole treatment, a small number 
(n=4) have shown a protective effect. Those that have shown lower rates have mainly been done 
among women who were known to be at a higher risk due to previous preterm births. For this 
reason it is not recommended that pregnant women be routinely screened for BV during 
pregnancy, as treatment for asymptomatic individuals does not appear to reduce the risk of 
adverse outcomes and may actually increase a woman’s odds of delivering early. In women with 
BV who have had previous preterm births, clinicians may use their discretion in providing 
treatment. [114] 
2.1.3 Epidemiology 
Using data from the 2001-2002 and 2003-2004 National Health and Nutrition Examination 
Survey (NHANES), studies have been able to look at prevalence of BV among women in the 
United States. For this study, BV was diagnosed in a research lab using Nugent’s criteria and 
demographic information was obtained through self-report on questionnaires. Overall, the 
prevalence of BV was nearly 30% for all women ages 14-49. [32] This number represents 
roughly 21.7 million women in US with BV. [35] Investigators looked at possible differences in 
rates among various subgroups. No difference was seen across the age groups included in this 
study or across the various income levels. Significant differences were found for race and 
education level. Overall, non-Hispanic blacks had the highest rate (51.6%), followed by Mexican 
Americans (32.1%) and non-Hispanic whites (23.3%). Other significant differences were found 
with education, where those with a high school education or higher were less likely to be positive 
(26%) compared to those with less education (33-34%). [32] When a logistic regression model 
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was used to adjust for socio-demographic information, the increased risk of BV among Mexican 
American women became non-significant; however, the increased risk among non-Hispanic 
blacks remained strong (OR: 3.13; 95% CI: 2.58-3.80). [32] Information from this data also 
indicates that 84% of women diagnosed with BV reported no symptoms. [35] 
A number of studies have reported similar racial disparity in BV. [49, 51, 115, 116] This 
difference is best demonstrated by two large US studies. The ABC study conducted in Seattle, 
Washington, enrolled a population-based sample of 400 parous women in a longitudinal study. 
At baseline, the investigators found a highly significant difference in the prevalence of BV by 
Nugent’s criteria among white (17%) and African American (45%) pregnant women (p<0.0001). 
[50] The second enrolled 1,886 pregnant women from obstetric practices at the Hospital of the 
University of Pennsylvania and found that 14% of the non-African American women enrolled 
had BV by Nugent's criteria compared to 46% of pregnant African American women. [52] A 
portion of the difference in these rates can be explained by other known risk factors, including 
socioeconomic status, douching, and sexual behavior. Still, studies which adjust for these factors 
continue to report large difference in the prevalence of BV between racial groups. A cohort study 
of 1,135 women from across the US, including 900 blacks, investigated a number of 
characteristics that might explain these differences. After adjusting for all important and 
significant socio-demographic and lifestyle factors, black women remained twice as likely as 
white women to have BV or intermediate flora as determined by Nugent’s criteria. [117] This 
study indicates that other factors are at play in causing these increased rates. The same study 
associated black race with lack of H2O2-producing lactobacilli, which would predispose these 
women to developing BV. [117] While no conclusive answer exists for the different rates, a 
number of theories exist. One popular theory is that black women have higher chronic stress 
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levels throughout life, which may influence their vaginal ecosystem. [118] A second possible 
explanation is that blacks have a more alkaline vaginal pH compared to whites, increasing their 
susceptibility to an overgrowth of abnormal bacteria. [117] More research is needed to determine 
the risk factors that may lead to differences in prevalence rates among racial and ethnic groups, 
both in the United States and around the world. 
2.1.3.1 Prevalence in India 
In India, few studies have estimated the prevalence of BV. Most studies have centered around 
the northern city of New Delhi. In a study at the Regional STD Centre at Vardhaman Mahavir 
Medical College (VMMC) and Safdarjung Hospital in New Delhi, information on reproductive 
infections was collected on 78,617 patients over a period of 14 years, beginning in January 1990. 
Most patients (~80%) seen were from the urban area of New Delhi, with very few coming from 
rural underserved areas. Only 3,966 of those patients were female. Information was divided into 
four time periods, each spanning roughly three years (1990-1993, 1994-1997, 1998-2001, 2002-
2004). From this data, it appears the prevalence of BV steadily decreased from the first time 
period, where 13.5% of females seen were diagnosed with BV, to the last time frame, where only 
4.5% of females seen were diagnosed with BV. [119] It is unclear from the information provided 
how patients were screened for BV and whether this method remained consistent throughout the 
study time frame. It is likely that the presented data is an underestimation of the true rate. This 
may also be due to the decline in the number of attendees and cases of all STIs that were 
reported during these years. The number of data reported from females declined dramatically 
throughout the study period, with the initial years reporting visits from 1,733 women and the last 
period only reporting data for 622. Since women had to be referred either through their husbands 
or the gynecology department, many cases of BV and other infections may have been dealt with 
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by physicians outside of the clinic. [119] Though the paper makes no reference to these issues, 
there is the possibility that patients began seeking treatment at other facilities that became 
available during these years. A cross-sectional study of 300 women from antenatal and 
gynecological clinics in New Delhi found that 14.3% of women had BV by Amsel’s 
criteria.[120] By contrast, a community cross-sectional study enrolling 301 women from an 
urban slum outside New Delhi found that the prevalence of BV was 41.5% by Amsel’s or 
Nugent’s criteria, with 40.2% of symptomatic women and 45.7% of asymptomatic women 
receiving a diagnosis.[121] One study in India looked only at 502 asymptomatic pregnant 
women at 14-28 weeks’ gestation in a rural area near New Delhi. Using Nugent’s criteria, the 
prevalence of BV was 8.6%, compared to 6.2% using Amsel’s criteria. [122] A population-based 
study of various housing areas in New Delhi looked at 122 women from an urban slum, 60 from 
a middle class area and 55 from the rural area (n=237). Using Nugent's criteria, they found that 
32.8% of the sample had BV. [123] The prevalence of BV varies greatly around the city of New 
Delhi depending on the population sampled and the diagnostic tests used (Table 4). Further 
studies will be needed to investigate the possible risk factors responsible for the differences.  
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Table 4. Studies of BV prevalence in and around New Delhi, India 
Author (Year) Study Design N Method of 
BV Diagnosis 
Population Prevalence of 
BV 
Ray (2006) Longitudinal 3,966 N/A* STD clinic, 
New Delhi 
4.5-13.5% 
Sharma 
(2004) 
Cross-
sectional 
300 Amsel Antenatal and 
gynecology 
clinics, New 
Delhi 
14.3% 
Sodhani 
(2005) 
Cross-
sectional 
301 Amsel and 
Nugent 
Urban slum, 
New Delhi 
41.5% 
Dadhwal 
(2010) 
Cross-
sectional 
502 Nugent and 
Amsel 
Rural New 
Delhi 
8.6% 
(Nugent) 
6.2% (Amsel) 
Bhalla (2007) Cross-
sectional 
237 Nugent Community 
based, New 
Delhi 
32.8% 
*Method of diagnosis not reported 
 
 
 A few studies have looked at other geographic regions of India and found similar 
prevalence estimates. The largest study was conducted in Goa and recruited 2,494 women ages 
18-50 from the community. Using Nugent’s criteria, this study found an overall prevalence of 
17.8%. [124] Similar results were found in four cross-sectional studies from other areas. The first 
was a study of 582 female sex workers in Chennai, where the overall prevalence by Nugent’s 
criteria was found to be 14.1%. [125]  The second studied 898 sexually active women 15-30 
years of age from reproductive health care clinics in Mysore and found prevalence rates by 
Nugent's criteria were found to be 19.1% (95% CI: 16.2-22.2). [126] The third conducted a 
cross-sectional study among female sex workers in Surat and found a prevalence of 17.4% by 
Nugent's criteria. [127] The fourth looked at 53 women presenting with abnormal vaginal 
discharge to the outpatient department at a hospital in Kolkata. The investigators found that 24% 
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of the women had BV by Nugent's criteria. [128] A cross-sectional study looking at a tribal 
population found a much higher rate of BV than reported in any other publication based on 
studies done in India. This analysis looked at 17 tribal villages in Madhya Pradesh looked at 326 
individuals with STI symptoms, including 211 women. Using clue cells as the main method of 
diagnosis, 64.1% (95% CI: 56.5-71.0) of women were diagnosed with BV. [129] The high 
prevalence in this study can be attributed to the fact that only individuals with symptoms of one 
sexually transmitted or reproductive tract infection were included in the population. In addition, 
the investigators used the presence of clue cells as the diagnostic criteria for BV. Though other 
Indian studies have shown the presence of clue cells to have a high sensitivity (67-77%) and 
specificity (92-94%) compared to Amsel’s criteria for the diagnosis of BV [121, 128], use of the 
full set of Amsel’s criteria or Nugent’s criteria is preferable.  
In summary, BV prevalence rates in India range from 5-64%.  [119, 129] As studies are 
sparse, more research is needed to determine the prevalence in various regions throughout the 
country using standardized techniques for BV assessment. From information available, it appears 
that geographic [121, 124, 125], ethnic [129], and socioeconomic [119, 125] status may play a 
role in determining prevalence. However, as the evidence for this is weak, additional studies 
examining a range of risk factors for BV among women in India are needed (Table 5).  
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Table 5. Studies of BV prevalence in India (excluding New Delhi area) 
Author (Year) Study Design N Method of BV 
Diagnosis 
Population Prevalence 
of BV 
Patel (2006) Cross-sectional 2,494 Nugent Goa 17.8% 
Uma (2005) Cross-sectional 582 Nugent Sex workers, 
Chennai 
14.1% 
Madhivanan 
(2008) 
Cross-sectional 898 Nugent Reproductive 
health clinics, 
Mysore 
19.1% 
Rao (2009) Cross-sectional 211 Clue cells Tribal 
villages, 
Madhya 
Pradesh 
64.1% 
Shethwala 
(2009) 
Cross-sectional 300 Nugent Sex workers, 
Surat 
13.33% 
Modak (2011) Cross-sectional 53 Nugent Hospital 
outpatient 
clinic, Kolkata 
24.0% 
 
2.1.4 Risk Factors for BV 
BV does not have one single cause. Though sexual practices seem to play a large role in the 
development of infection [29, 130-134], there are a number of other risk factors that seem to be 
important. Douching [42-44, 135-138] and use of contraceptives [132, 139-146] are two of the 
most researched and developed areas of research and have the most convincing evidence 
regarding exposure. Hygiene is a potential risk factor in the development of BV. [147-149] 
However, current research is lacking and needs to be further developed before any conclusions 
can be drawn. A number of other risk factors have also been investigated and found to be 
potentially important, including smoking[45, 150] and stress levels.[48, 50, 151] 
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2.1.4.1 Douching 
Current research indicates that there are no known health benefits to douching. [136, 137] A 
number of studies have shown a link between douching and development of BV. A retrospective 
study of 947 women with BV looked at the number and type of lactobacilli identified in vaginal 
flora and analyzed the results based on risk factors assessed in interview. A total of 756 women 
did not have H2O2-producing lactobacilli present at the time of analysis. Among women with BV 
by Nugent score, the odds of not having H2O2-producing lactobacilli were 2.6 (95% CI: 1.2-5.5) 
times higher among those who douched in the past week and 2.7 (95% CI: 1.1-6.4) times higher 
for those who reported douching at least twice in the past month. After adjusting for other 
significant factors, this relationship remained significant (ORadj: 2.5; 95% CI: 1.1-6.0). [152] 
Since H2O2-producing lactobacilli may play a major role in the development of BV, this 
information may provide insight into the reason why someone relapse while others are cured 
following treatment. A cross-sectional study of 496 women assessed for BV by Nugent score 
self-reported risk factors and other socio-demographic information. Women who reported use of 
a vaginal douche in the past two months had 3.6 times (95%CI: 2.0-6.2) the risk of BV than 
those women who reported not douching or douching less frequently. This relationship 
weakened, but remained significant when adjusted for ethnicity, education, and hormone use 
(ORadj: 2.9; 95% CI: 1.5-5.6). [131] 
Several other studies have been unable to find a relationship between douching and BV. 
A cross-sectional study conducted among women ages 16 to 35 who reported having sex with 
other women found no relationship between douching in the prior 30 days and BV (RR: 1.53; 
95% CI: 0.90-2.58). [31] Another cross-sectional study looking at women < 12 weeks’ gestation 
found a significant increase in the odds of BV among women who reported douching during 
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pregnancy (OR: 1.80; 95% CI: 1.31-2.46), but this became non-significant when adjusted for 
age, race, socio-demographic information, smoking, and STD history (OR: 1.20; 95% CI 0.86-
1.57).[52] A cross-sectional study of sex workers in Brazil found no significant relationship 
between douching and development of either grade II or grade III vaginal flora, even when 
breaking out douching habits by reason and frequency (adjusted Prevalence Risk: 1.17; 95% CI: 
0.80-1.71).[44] Finally, one study combined both cross-sectional and prospective analysis to 
analyze multiple time-points for 1193 women who were followed for 3 years, with douching 
assessed every six months. In the cross-sectional analysis, women who douched during the 
period analyzed were only at an increased risk for BV if they also had BV at the prior visit. 
When the data was analyzed longitudinally, no overall association was found for douching and 
BV, but among women with intermediate flora, there was a slight increase in the risk of 
acquiring BV (HR: 1.5; 95% CI: 1.1-2.4).[42] These data suggest that douching may only be a 
risk factor for certain categories of women who also have other strong risk factors for the 
development of BV. 
 The majority of studies done to look at the association between douching and BV are 
cross-sectional in nature. As many women douche as a way of dealing with the symptoms of BV 
determining a temporal relation is difficult. Two studies have been able to overcome some of 
these difficulties to better understand the relationship. First, a longitudinal study of 39 women 
who douched allowed women to continue douching normally for the first four weeks, and then 
asked them to stop for a follow-up period of 12 weeks. Finally, participants were allowed to 
either continue douching cessation or return to their normal practice for the last four weeks. 
Vaginal samples were taken twice weekly during the first two stages and once at the end of the 
last phase. Overall, there was not a significant reduction in BV during the douching cessation 
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phase (ORa: 0.76; 95% CI 0.33-1.76). When only women who reported douching for the purpose 
of removing menstrual blood were analyzed, a significant reduction was seen (ORa: 0.23; 95% 
CI 0.12-0.44).[135]  This same difference was not seen when looking at women who reported 
douching to remove vaginal odor or to feel clean. While the author postulated that there might be 
some synergistic effect between disruption in vaginal flora due to menstruation and douching, it 
may also be possible that the effect is seen only among women who were not douching as a way 
to deal with symptoms of abnormal vaginal flora. A second longitudinal study followed 3,620 
non-pregnant women for a period of one year. Participants were assessed quarterly for BV by 
Nugent’s criteria and asked about douching practices in the prior three months. The investigators 
used marginal structural models to adjust for douching practices, including adjustment for 
douching practiced by women who already had BV. Overall, they found that women who 
practiced douching were at a 21% increased risk of developing BV (OR: 1.21; 95% CI: 1.08-
1.38).[43] The evidence from these two studies suggests that for women who are not douching as 
part of self-treatment for vaginal symptoms, douching increases the risk of developing BV. This 
information may explain why evidence from cross-sectional studies is mixed on the overall risk 
and effect of vaginal cleansing.  
Evidence for douching as a risk factor for BV is still mixed. While much evidence points 
toward a moderate association, an equal amount points to no relationship. Likely, douching is 
one of many risk factors that lead to infection in individuals who are already at a higher risk. As 
a modifiable risk factor, douching is something that can be discouraged by medical professionals 
as a way to help avert new and recurrent BV.  
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2.1.4.2 Sexual risk factors 
Though BV is often included in references relating to sexually transmitted infections (STIs), it is 
not considered to be part of this category. While there are sexual risk factors for contracting BV 
and some transmission may occur via intercourse, not all infections occur this way. As BV is a 
polymicrobial infection, it is possible that this difference may be due to certain bacteria being 
sexually transmitted infections while others are transmitted via other routes. There are a number 
of sexual risk factors that have been shown to be possibly related to BV infection.  
Hormonal contraceptive use has been shown to have a protective effect against BV 
infection in a number of studies. A cohort study of 330 women from two STD clinics in 
Baltimore was studied to look at the effect of hormonal contraception on BV diagnosis. 
Compared to women who were not using any contraceptives, those using a progestin only 
method had a decreased risk for subsequent BV diagnosis (ORadj: 0.42; 95% CI: 0.20-0.88). 
Women using a combination method had a decreased, but non-significant risk of BV (ORadj: 
0.66; 0.39-1.10).[153] In one of the largest cohort studies to date, 3077 women were followed to 
look at the association between use of various contraceptives and BV. A decreased risk of BV 
prevalence among pill users (OR: 0.76; 95% CI: 0.63-0.90) and injection/implant users (OR: 
0.64; 95% CI: 0.53-0.76) was noted. [140] In a comparative cohort study of 123 IUD users and 
108 oral contraceptive users, the authors found that IUD users had nearly three times the risk of 
developing BV compared to those using oral contraceptives (RR:2.8; 95% CI: 1.5-5.1).[154] 
Results from these and other studies have almost universally found a decreased risk of BV 
among hormonal contraceptive users. [139, 141, 142, 155, 156] 
Two theories exist as to why hormonal contraceptives may decrease the risk of BV. First, 
adequate estrogen levels increase glycogen production, which serves as a food source for 
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Lactobacilli. Second, hormones, especially progestin, inhibit uterine bleeding. As menstruation 
causes shifts in the vaginal flora, this inhibition may help to maintain overall balance in the 
vagina.[157]  
As the previously discussed study indicates[154], many studies show that intrauterine 
device (IUD) users are at an increased risk of developing BV.[139, 141, 144, 145, 154, 158] 
Many of the problems associated with IUDs are a result of an early version, the Dalkon Shield, 
which had a multifilament string which allowed easy passage for bacteria from the vagina to the 
uterus. The Dalkon Shield was associated with a high rate of infection and was removed from the 
market in the mid-1980s as a result. Current IUDs use a monofilament string and are considered 
relatively safe for use. Current research indicates that IUD use is not associated with increased 
risk of BV. A 2008 study compared the change in vaginal flora following insertion of a copper 
IUD in 78 women compared with a progesterone-incorporated IUD (Mirena) inserted in 94 
women. Patients were assessed for BV at a visit less than a month before insertion, again at four 
to six weeks post-insertion, and a third time at 6 months post-insertion. At the first follow-up 
appointment, 3.9% of those receiving a copper IUD and 1.4% of those receiving Mirena who had 
normal flora at insertion had developed BV using Ison-Hay criteria (p=0.38). At the six month 
follow-up, 7.3% of those using the copper IUD and 2.8% of those with Mirena who had normal 
flora at baseline had developed BV (p-0.30).[159] Interestingly, this study did show a significant 
difference in the patient reported rates of abnormal vaginal discharge among those receiving 
Mirena compared to those receiving a copper IUD (p=0.04), which is likely due to other changes 
in the uterine lining associated with hormonal IUD use. [159] Another longitudinal study from 
2011 examined changes in vaginal flora of 286 women for up to two years post-insertion of a 
hormonal IUD (Mirena) found that there was no significant difference in the rate of infection a 
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year after insertion (no p-value provided), though they did show a slight increase in risk among 
first time users for all infections (OR: 1.7; 95% CI: 1.1-2.8). However, this last number included 
BV, Candida, and aerobic vagintis, making it difficult to determine whether there was a true 
increase in the rates of BV. [160] Other studies have shown that rates of BV are higher among 
IUD uses than among those using oral contraceptives. [140, 161] As previously discussed, oral 
contraceptives may have a protective effect. Those with IUDs may not be at an increased risk, 
but have a normal risk that appears high when compared to oral contraceptive users. This may be 
especially true for studies involving copper IUDs, which are commonly used outside of the 
United States. IUDs containing similar hormones to oral contraceptives may have a similar 
protective effect. Overall, any increased risk associated with current IUDs is small and may be 
due to other risk factors for women choosing to use IUDs over other forms of contraceptives.  
Condoms also seem to lower the risk of BV infection. A study of 871 high risk women in 
a case-crossover analysis was followed for three years. Those who reported consistent condom 
use were half as likely to develop BV compared to those who did not use condoms (OR: 0.55; 
95% CI: 0.35-0.88). When the authors compared those with normal flora to those with BV by 
Nugent criteria, excluding the intermediate flora category, they found an even stronger 
relationship (OR: 0.37; 95% CI: 0.20-0.70).[132] Additional studies have found a similar 
reduction in risk for those using condoms, with the greatest benefit coming from consistent use. 
[134, 139, 142] Still, some studies have found null results. [143, 162-164] The evidence from 
studies of condom use and BV provide insight into one of the potential pathways of transmission. 
Sexual activity is a consistently cited risk factor for BV throughout the literature, with commonly 
found factors including number of sexual partners[130, 133] and new sexual partners.[130, 165-
168] Perhaps the most convincing evidence comes from lesbian studies, where concordance 
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between partners is typically found to be high. [31, 169, 170] Conversely, many patients who 
develop BV report not being sexually active and others do not have any of the high risk 
behaviors.[171] Overall, evidence points to multi-causal pathways, with sexual activity and 
behavior being a strong exposure.  
2.1.4.3 Hygiene 
The association between rectal bacteria and the development of BV is a newly developing area 
of research. In a study of 148 women with BV by Amsel’s criteria and 69 women with healthy 
vaginal flora, rectal samples were taken and examined for four different organisms associated 
with BV. In women with BV, M. mulieris was found in 56%, M. curtisii in 62%, G. vaginalis in 
45%, and M. hominis in 54%. These percentages are much higher than among the healthy 
women, where the most commonly found pathogen, M. curtisii, was only found in 14% of 
samples.[147] A more recent study looking at 132 pregnant women examined at 35-37 weeks’ 
gestation found a number of similarities between bacteria colonies in the vagina and the rectum. 
A total of 63 species were examined for this study. Nine were found only in vaginal colonies, 26 
only in rectal colonies, and 29 in both locations.[148] The findings from this study are mainly 
applicable to species of lactobacilli, as are the results from many other studies. Specifically, a 
number of studies point to L. crispatus, L. gasseri, and L. jensenii as being harbored in both the 
vagina and rectum. [148, 149, 172] There is less evidence that BV-associated bacteria are also 
housed in the rectum. One major study found that there was little similarity between the 
Bifodobacterium species found perianally in women with the bacteria found at vaginal sites, with 
the exception of G. vaginalis. [173] Given this information, there is a growing body of literature 
pointing toward the role of rectal colonies in the prevention and development of BV. If a link 
does exist, hygiene and sanitation may be potentially modifiable risk factors for BV.  
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2.1.5 Adverse outcomes associated with BV among pregnant women 
BV has been associated with a number of adverse pregnancy outcomes, including spontaneous 
abortion (loss of a pregnancy at <22 weeks’ gestation), and birth of a preterm (<37 weeks’ 
gestation), low birth weight (<2,500 grams), small for gestational age (<10th percentile by sex 
and gestational age) and growth restricted infant (<5th percentile by sex and gestational age).  
2.1.5.1 Spontaneous abortion 
 
The link between BV and spontaneous abortion remains unclear. While many studies have found 
an association between the two, other studies have failed to find an increased risk of spontaneous 
abortion in women with BV or have only shown an association at specific time points. The 
majority of studies have been prospective cohorts that recruited women from prenatal clinics 
during the first trimester. In an early cohort study of 461 British women who presented to a 
hospital for their first antenatal clinic between nine and 16 weeks’ gestation found an association 
between grade II and grade III flora, as determined using a modified version of Spiegel’s 
method, and spontaneous abortion and preterm birth (ORa: 5.5; 2.3-13.3).[70] As this study did 
not separate the two outcomes for analysis, it is difficult to determine whether the large odds 
ratio is a result of an increase in the risk of spontaneous abortion, preterm birth, or both. In two 
cohorts of women being followed to determine the best method of treatment for a variety of 
vaginal infections, a total of 1138 women were screened for BV at registration (mean 16-18 
weeks’ and 20 weeks’ gestation) using Amsel’s criteria. Overall, the researchers found that 
women with BV had a three-fold increased risk for spontaneous abortion. (RR: 3.1; 95% CI: 1.4-
6.9).[20] Another cohort study using Amsel’s criteria to diagnose 228 Belgian women at <14 
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weeks’ gestation found that women with BV were 5.4 times more likely to have a spontaneous 
abortion than those without BV  (RR 5.4 95% CI: 2.5-11.0) In addition, women with a grade III 
lactobacillary flora as defined by Schroder’s classification system (RR: 5.4; 95% CI: 2.0-7.8) and 
women with clue cells (RR, 5.4: 95% CI, 2.5-11.0) were also at an increased risk of spontaneous 
abortion compared to women with normal slides.[174] Tripathi et al. enrolled 200 women at their 
first prenatal visit (<18 weeks’ gestation) at a tertiary hospital in New Delhi, India, and tested 
them for BV using Amsel’s criteria. Overall, the investigators found that women with BV were 
7.5 times more likely to have a second trimester abortion compared to women without BV (OR 
7.50; 95% CI: 1.28-56.0).[175] While this study found an extremely high risk, only eight 
spontaneous abortions were identified within the study population, giving little data with which 
to calculate risk. The authors did not provide a mean gestational age at enrollment, but based on 
the fact that new data for first trimester abortions were reported, it is likely the majority of 
women was recruited in the second trimester and was past the periods of highest risk. In a 
prospective study of Italian women seen in an antenatal clinic at < 10 weeks’ gestation, Guerra et 
al reported that women who’d experienced at least one preterm birth who screened positive for 
BV using Nugent’s criteria between 3 and 12 weeks’ had nearly a six fold increased risk of 
spontaneous abortion compared to women with normal flora after adjusting for previous 
miscarriages and prior preterm births  (ORa: 5.71; 95% CI: 2.92-11.1).[176] In addition, they 
showed that women with intermediate flora had a similar increase in risk (ORa: 5.30; 95% CI: 
2.92-9.60).[176] The most convincing evidence for the link between BV and spontaneous 
abortion comes from two meta-analyses performed by Leitich et al. The first, conducted in 2003,  
looked at three studies with a total of 856 participants and found almost a ten-fold increase in the 
risk of spontaneous abortion among women with BV (OR: 9.91; 95% CI: 1.99-49.34). [177] In 
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2007, they updated the analysis and looked at five papers examining the relationship between 
late miscarriages and found that women with BV were at a significantly increased risk of 
spontaneous abortion (OR 6.32; 95% CI: 3.65-10.94) and women with intermediate flora had a 
lower, non-significant increase in risk (OR 2.7; 95% CI: 0.94-8.14).[178]  
Other studies have shown no association between BV and spontaneous abortion. In a 
cohort study of 168 South African women recruited at <30 weeks’ gestation, Govender et al. 
found no significant difference in the rate of spontaneous abortion between women with BV 
diagnosed using Nugent criteria, women with other vaginal infections, and women with no 
infection.[179] However, the high rate of infection (71%), in particular BV (52%), made 
comparison difficult due to the small number of women who were in the normal category. 
Second, the average gestation age at enrollment was 26 weeks’, meaning that a large number of 
women in the study were already past the cutoff for spontaneous abortion before they began 
observation.  In a large cohort study of 1916 participants screened for BV using Nugent criteria 
at <12 weeks’ gestation, Nelson et al. found no relationship between BV and spontaneous 
abortion (HR: 1.17; 95% CI: 0.78-1.75). This relationship remained the same when the authors 
adjusted for gestational age at enrollment, maternal age at enrollment, cigarette use, African-
American race, vaginal bleeding, and a history of incompetent cervix (HRa: 0.84; 95% CI: 0.38-
1.87). A significant result was found when continuous scores were used instead of a dichotomous 
exposure (HRa: 1.24; 95% CI: 1.02-1.64). In addition, when the authors compared women with 
scores of seven to 10 (BV) with women with scores of zero to three (normal), they found a 2.5 
fold increase in risk for spontaneous abortion among those with higher scores (HRa: 2.49; 95% 
CI: 1.13-5.48).[180] These results may indicate that a larger change in the vaginal flora is 
associated with an increased risk of spontaneous abortion.  
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Some studies have shown no overall association between BV and spontaneous abortion, 
but have demonstrated an increased risk for late miscarriage. Llahi-Camp et al. performed a case-
control study of  500 non-pregnant women who had had at least three consecutive miscarriages 
to look at whether BV diagnosed using Spiegel’s method was associated with early (<13 weeks’ 
gestation) and late (>13 weeks’ gestation) miscarriage. They found that women who had 
experienced at least one late miscarriage were more likely to have BV (27/130; 21%) compared 
to women who had only experienced early miscarriage (31/370; 8%) (p<0.001). This same 
association held when they only looked at women who’d had at least one term pregnancy 
(p<0.001).[181] In a larger cohort study of 1201 British women recruited at <10 weeks’ 
gestation, Oakeshott et al. found no relation between BV diagnosed using Nugent’s method and 
miscarriage at <16 weeks gestation (OR 1.15; 95% CI: 0.70-1.87). However, when the 
investigators looked at spontaneous abortion in three different time categories, they found no 
association for loss at <10 weeks’ gestation (OR 0.53; 95% CI 1.19-1.47) or at 10 to 12 weeks’ 
gestation (OR 1.32; 95% CI 0.67-2.62), but found a positive association between BV diagnosis 
and spontaneous abortion at 13 to 15 weeks’ gestation (OR 3.45; 95% CI: 1.16-10.29).[182] 
However, the smallest number of spontaneous abortion occurred during this last time category 
(14) compared to the earlier time categories (51 and 56, respectively). This may contribute to 
increase odds ratio and wide confidence interval. While the study recruited women at <10 weeks' 
gestation, seven weeks' was the mean gestational age at enrollment. Further, this study only 
followed women until 16 weeks' gestation, providing a narrow window. Finally, women were 
interviewed about their pregnancy outcome at 16 weeks'. Only a very small amount (9%) of the 
data came from medical charts. Women may fail to report spontaneous abortion or be unaware of 
them at the time of interview, contributing to the low number. In a follow-up to this study of 912 
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pregnant women, Oakeshott et al. looked at the same cohort, this time looking for an association 
between late miscarriage (13-23 weeks’ gestation) and BV. Overall, they found BV- positive 
women were four times as likely (RR: 4.0; 95% CI: 1.3-12.1) as BV-negative women to have a 
spontaneous abortion at this later time point.[183]  This result is consistent with the earlier study 
where they showed a relationship between the latest time point measured (13 to 15 weeks’) and 
BV. The above studies have a number of important limitations. First, they only enrolled women 
who presented to a prenatal clinic, and, thus, only included women with clinically recognized 
pregnancies. Second, women were only tested for BV at enrollment. Studies have shown that 
vaginal flora shifts can occur very quickly. These studies are unable to identify whether the 
woman had an infection at the time of the spontaneous abortion. Third, only two of the studies 
adjusted for confounders. [176, 180] Previous miscarriages, as well as having carried a previous 
pregnancy to term, were adjusted for in one [176], while the other adjusted for maternal age, 
race, cigarette use, and vaginal bleeding. [180] All of these factors play a potential role in 
spontaneous abortion and may explain some of the difference in findings between studies. 
Finally, most of these studies enrolled a small sample size [70, 174-176, 181] and thus have wide 
confidence intervals (Table 6).  
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Table 6. Select prospective cohort studies of spontaneous abortion and BV 
Author 
(Year) 
Study 
Design 
N Method of BV 
Diagnosis 
Time of BV 
Diagnosis 
Results (95% CI) 
Donders 
(2000) 
Prospective 
cohort 
218 Schroder <14 weeks’ 
gestation 
RR: 5.4 (2.5-11.0) 
Guerra 
(2006) 
Prospective 
cohort 
242 Nugent <9 +6 weeks’ 
gestation 
ORa: 5.71 (2.92-
11.1) 
Hay 
(1994) 
Prospective 
cohort 
461 Modified 
Spiegel 
<16 weeks’ 
gestation 
ORa:5.5 (2.3-13.3) 
McGregor 
(1995) 
Prospective 
cohort 
1138 Amsel 16-20 weeks’ 
gestation 
RR: 3.1 (1.4-6.9) 
Nelson 
(2007) 
Prospective 
cohort 
1916 Nugent <12 weeks’ 
gestation 
HRa: 0.84 (0.38-
1.87) 
Oakeshott 
(2002)  
Prospective 
cohort 
1201 Nugent <10 weeks’ 
gestation 
RR: 1.14 (0.70-
1.87) 
Oakeshott 
(2004) 
Prospective 
cohort 
974 Nugent <10 weeks’ 
gestation 
RR: 4.0 (1.3-
12.1)2 
Tripathi 
(2003) 
Prospective 
cohort 
155 Amsel <18 weeks’ 
gestation 
OR: 7.50 (1.28-
56.0) 
1Mean age at gestation for entry to study 
2RR is for late miscarriages (13-23 weeks' gestation) only 
 
 
To overcome the bias that occurs by only recruiting women with a clinically recognized 
pregnancy, some studies have recruited women undergoing in-vitro fertilization (IVF) treatment. 
In these instances, the investigators are able to determine BV status prior to conception, 
determine the exact date that conception occurred, and closely monitor women for early 
pregnancy losses. A British cohort study of 301 women attending an IVF treatment found that 
BV diagnosis using a modified version of Spiegel’s method was not associated with increased 
risk of spontaneous abortion (no p-value provided).[184] In a cohort study of 771 women 
undergoing IVF at a hospital clinic in England, Ralph et al. found that women diagnosed with 
BV using a modified version of Spiegel’s method were twice as likely to have a spontaneous 
abortion as those without BV (RRa 2.03; 95% CI 1.09-3.78). Additionally, this study divided 
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spontaneous abortions into four categories based on the timing. Notably, women with BV were 
2.5 times more likely to have a preclinical pregnancy loss, defined as a positive pregnancy test 
followed by spontaneous abortion before 6 weeks’ of gestation and before confirmation of the 
pregnancy by ultrasonography, than those without BV (RRa: 2.69; 1.47-4.92).[185] In a cohort 
study of 91 women presenting for their first IVF cycle at the University of Washington, there 
was no significant association between diagnosis of BV by Nugent’s criteria prior to embryo 
transfer and subsequent pregnancy loss five weeks later when the authors compared the women 
with intermediate flora to those with normal flora (p=0.2). A comparison between women with 
BV and those with normal flora was not undertaken because only three women with BV became 
pregnant following the first round of IVF treatment, compared to 12 with intermediate flora and 
26 with normal flora, providing little statistical power to test the association. [186] While these 
studies are able to capture data from conception onward, the results are not generalizable. 
Women in these studies suffered from an array of reproductive problems including 
endometriosis[184], ovulatory disorder[184], recurrent miscarriage[185], polycystic ovary 
syndrome[185], and varying causes of infertility more often than would be expected in the 
general population.  
If an association between spontaneous abortion and BV exists, it is unknown exactly 
what the biological pathway would be. Since BV is associated with endometritis, it is a potential 
mediator between BV and spontaneous abortion. [187, 188] On the other hand, ascent of bacteria 
from the vagina through the cervix during pregnancy may cause deciduitis, chorioamnionitis, and 
amniotic fluid infection, all of which may play a role in spontaneous abortion.[187, 189] 
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2.1.5.2 Preterm Birth 
The literature surrounding the association between BV and preterm birth is also conflicted. 
Overall, the literature suggests that the risk for preterm birth may be greatest in women who have 
abnormal flora early in pregnancy. Four prospective cohort studies screening women for BV at 
<22 weeks gestation have found that women positive for BV by gram stain have an increased 
risk of preterm birth, with significant ORs ranging from 1.1-6.9. [175, 176, 190, 191] The first of 
these studies screened 490 pregnant women in Indonesia for BV by gram stain at 16 to 20 weeks' 
gestation and again at 28 to 30 weeks' gestation. They found significant results when screening 
occurred at<20 weeks gestation (OR: 2.0, 95% CI: 1.0-3.9), but not when screening occurred at a 
later time point (OR: 1.5, 95% CI: 0.7-3.0).[192] Results are mixed regarding the association 
between the time of screening for BV and preterm birth. Two prospective studies screened 
women during the second trimester, the first between 23 and 26 weeks’ gestation. This study 
found that BV diagnosed as a vaginal pH >4.5 and a gram stain score ≥7 was associated with an 
increased risk of preterm birth (OR: 1.4, 95% CI: 1.1-1.8).[193]  A second study diagnosed 635 
pregnant women by gram stain at <35 weeks’ gestation and found an increased risk of preterm 
birth (RR:3.1, 95% CI: 1.8-5.4).[88] In a meta-analysis of 20,232 pregnant women, BV was 
associated a 2-fold risk for preterm delivery at <37 weeks (OR: 2.19, 95% CI: 1.54-3.12).[177]  
A prospective study of 1,026 women screened for BV using a modified Spiegel method at the 
first prenatal visit found an increased risk for preterm birth among women with BV (OR: 2.4; 
95% CI: 1.1-4.7) and a similar risk for those with abnormal flora, but not BV (OR: 2.4; 95% CI: 
1.2-4.8). [194] Some studies have reported that diagnosis of BV in the first or second trimester is 
more predictive of preterm birth, with RRs ranging from 2.0 to 3.3. [176, 178, 192, 195] One 
prospective cohort study of 490 women screened for BV found that women screened at 16-20 
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weeks’ gestation had a significantly increased risk of preterm birth (RR: 2.0; 95% CI: 1.0-3.9), 
but women screened at 28-32 weeks’ gestation did not have a significantly increased risk (RR: 
1.5; 95% CI: 0.7-3.0).[192] In a meta-analysis of 20,232 pregnant women, BV was associated 
with a 2-fold increased risk for preterm delivery at <37 weeks' (OR: 2.19; 95% CI: 1.54-3.12). 
The meta-analysis included both high and low risk women screened between 9 and 30 weeks’ 
gestation, with differing criteria for BV diagnosis.[177] A subgroup of individuals from this 
analysis who were screened at <16 weeks of gestation had a higher risk for preterm delivery than 
those screened at <20 weeks with odds ratios of 7.55 (95% CI: 1.80-31.65) and 4.2 (95% CI: 
2.11-8.39), respectively.[177]  This meta-analysis was later refined to include literature 
published after May 2005, adding 14 studies and 10,286 patients to the previous analysis 
resulting in a total of 32 studies and 30,518 patients.[178] This analysis found a similar increase 
in risk for preterm birth among women with BV as what was reported in the earlier analysis (OR: 
2.16, 95% CI: 1.56-3.00). When additional analyses were done to determine if the risk for 
preterm birth was different depending on when screening was performed, no significant 
differences were found(OR not reported).[178]  However, results are mixed as others have found 
no association between time of screening for BV and preterm birth. [178, 181, 196]   
Other prospective studies have found no significant difference in rates of spontaneous 
preterm birth between women with and without BV. [183, 197, 198] One of these studies 
screened 2,929 women between 22 and 24 weeks’ gestation.[198] BV by gram stain was 
associated with preterm birth only in multiparous women who delivered at <32 weeks gestation, 
with BV accounting for 11% of the attributable risk for preterm birth. [198] A prospective cohort 
of 2221 women screened for BV at <24 weeks’ gestation using Amsel’s criteria found no 
association between BV and risk for preterm birth (OR: 0.8; 95% CI: 0.5-1.5).[199] A similar 
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prospective cohort screened 1216 women at <10 weeks’ gestation using Nugent’s criteria and 
found no association between BV and preterm birth (RR: 0.9; 95% CI: 0.4-2.2). [183] Finally, a 
case-control study of 5,092 women screened for BV by Nugent’s criteria at 26 weeks’ gestation 
found that BV was not associated with preterm births (OR: 1.2; 95% CI: 0.5-2.4). [200] In 
summary, preterm birth and BV have been studied in a number of different populations. 
However, the information garnered from these investigations does not provide a clear picture of 
the role BV plays in preterm birth. While many studies report significant findings, others have 
been unable to show any association. Further research is needed to determine whether BV is an 
important risk factor for preterm birth and whether the point in pregnancy when it is diagnosed is 
significant (Table 7). 
 
Table 7. Select prospective cohort studies of preterm birth and BV 
Author  
(Year) 
N Method of BV diagnosis Timing of BV diagnosis Results (95% CI) 
Hillier  
(1995) 
10,397 Nugent + vaginal pH >4.5 23-26 OR 1.4 (1.1-1.8) 
Gratacos  
(1998) 
635 Gram stain <35 RR 3.1 (1.8-5.4) 
Riduan  
(1993) 
490 Gram stain 16-20 
28-32 
RR 2.0 ( 1.0-3.9) 
RR 1.5 (0.7-3.0) 
Thorsen  
(2006) 
2221 Amsel <24 OR 0.8 (0.5-1.5) 
Oakeshott  
(2002) 
1216 Nugent <10 RR 0.9 (0.4-2.2) 
Donders  
(2009) 
1026 Modified Spiegel First prenatal visit OR 2.4 (1.1-4.7) 
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2.1.5.3 Low birth weight 
Few studies have examined the link between BV and delivery of a low-birth weight (<2500g) 
infant. Of the four studies that have, three have shown a significant positive relationship between 
BV and low-birth weight, [19, 193, 201] while the fourth showed borderline results. [202] A 
cohort study of 3,540 pregnant women screened for BV at <20 weeks’ gestation through 
Schmidt’s method. This study found an increased risk for delivery of a low-birth weight infant 
(OR 1.95, 95% CI: 1.3-2.9)[19] A prospective cohort of 10,397 women screened for BV by gram 
stain at 23-26 weeks’ gestation found that BV was related to the preterm delivery of a low-birth 
weight infant (OR 1.4, 95% CI:1.1-1.8).[193] This study only looked at the relation between BV 
and preterm delivery of a low-birth weight infant, not at low-birth weight term infants. A cross-
sectional study of 49 women in idiopathic preterm labor and 38 term controls were screened for 
BV using Amsel’s criteria at presentation for labor. Of the women in the study who delivered 
prematurely, 67% of the ones with BV delivered a low-birth weight infant, compared to 22% of 
women without BV (p<0.0005)[201] This study also only looked at low-birth weight infants 
born prematurely, not at low-birth weight term infants and also had an extremely small sample 
size. Lastly, a prospective study of 2,662 women screened at 17 weeks’ gestation using Amsel’s 
criteria found an increased risk of a low-birth weight infant in women with both BV and 
Ureaplasma urealyticum (OR 3.1, 1.8-5.4), but not in women with only BV (OR 0.8, 95% CI: 
0.3-2.2).[202] None of these studies measured BV prior to conception or at various time point 
throughout pregnancy (Table 8).  
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Table 8. Studies of BV and low birth weight 
Author 
(Year) 
N Study Design Method BV of 
Diagnosis 
Time of BV 
Diagnosis 
Results (95% CI) 
Svare 
(2006) 
3,540 Prospective 
cohort 
Schmidt <20 Weeks OR 2.0 (1.3-2.9) 
Hillier 
(1995) 
10,397 Prospective 
cohort 
Nugent 23-26 weeks’ OR 1.4 (1.1-1.8) 
Holst 
(1994) 
87 Cross-
sectional 
Amsel 23-35 weeks’ P < 0.0005* 
Vogel 
(2006) 
2,662 Prospective 
cohort 
Amsel 17 weeks’ OR 0.8 (0.3-2.2) 
*OR not reported 
 
2.1.5.4 Small for gestational age and intrauterine growth restriction 
Very little research has been done on the potential role of BV in the birth of either a small for 
gestation age (SGA) or intrauterine growth restricted (IUGR) infant. Only two published studies 
have looked at this relationship. The first, a prospective study of 2221 low-risk women screened 
for BV at <24 weeks’ gestation using Amsel’s criteria, found that women with BV had a non-
significant increase in risk for having a small for gestational age infant compared to women 
without BV (ORa: 1.6; 95% CI: 0.7-3.1). [199] In the second, investigators conducted a matched 
case control study of 65 women who gave birth to a single infant with a confirmed diagnosis of 
IUGR and 65 controls. The authors found that genital infections, including BV, were a 
significant risk factor for IUGR (p=0.006). [203] This study did not break down risk further by 
type of infection, making it difficult to determine whether BV or another infection of interest was 
responsible for the increased risk. Based on the information currently available, there is little 
evidence that BV is associated with IUGR. It is possible that the association between BV and 
low birth weight is driven by the preterm births in the population. Further research is necessary 
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to determine whether an increased risk exists and what the possible biological mechanism 
involved might be.  
2.1.6 Public health significance 
The relationship between BV and pregnancy outcomes is unclear. While a number of studies 
have been conducted, results fall in both directions. A better understanding of the possible 
relationship between BV and these outcomes could help to dictate future screening and treatment 
policies for pregnant women as part of an effort to reduce spontaneous abortion, low birth 
weight, and preterm birth. In addition, the information would inform screening procedures in 
pre-pregnant women so infections could be treated and cleared prior to conception.  
2.2 CONSANGUINEOUS MARRIAGE 
Consanguineous marriages (CM) are common in many parts of the word. CM may be defined as 
a union between two individuals who are related as second cousins or closer. [27] This definition 
is based on the amount of genetic influence expected. Individuals who are related to a lesser 
degree would not be expected to share any more genetic makeup than two random people from 
the population.[27] Relatedness is typically expressed using the coefficient of inbreeding (F), 
which corresponds to the amount of inherited identical gene copies from each parent. For first 
cousins, this produces an F=0.0625 or 6.25% of all gene loci will be identical. [27, 204] In areas 
with a high degree of inbreeding, considerations need to be made for previous CMs, which may 
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influence whether more distant relations are included in the definition of consanguineous 
marriage.[204] 
Prevalence of CM varies around the world, with most occurring in North Africa, the 
Middle East, and West Asia. [27, 204] North America, South America, most of Europe, 
Australia, and other developed areas have a prevalence of less than 4%. [204] The highest rates 
in the world are seen in the Middle East. However, several other pockets exist that have higher 
rates. One of these is South India, which has an estimated rate of 20-40%, depending on the 
specific State.[27] This is in contrast to the much lower rates found in the Northern region of the 
country, which are estimated to be between one and ten percent.[27] First cousin marriages 
comprise the largest portion of CMs, about 20-30%.[204]  
Reasons for consanguineous marriages differ between geographic regions. Religion often 
plays a large role in deciding what types of relations are allowed to marry and different sects 
may have different rules. For example, the Aryan Hindus in the northern part of India do not 
allow marriages between close relatives and dictate that there must be a minimum of five or 
seven generations between relatives on the female and males, respectively, side.[27] By contrast, 
first cousin marriages are common and allowed by the Dravidian Hindus in the southern part of 
the country. These related marriages are encouraged, especially among first cousins. In addition, 
uncle-niece marriages are commonplace.[27] This explains the large difference in prevalence 
between the two regions. Sikh groups often forbid consanguineous marriage, though 
enforcement largely depends on the area. Judaism and Islam both allow for first cousin and 
double first cousin marriages, but Judaism also allows for uncle-niece relationships.[27] While 
religious doctrine plays a large role, the laws of the country also factor in to the prevalence. 
While Judaism doctrine allows for CM, the laws of many countries where these individuals live 
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do not allow for first cousin or closer marriages. In addition, the effects of years of related 
marriage have been brought to light, especially in closed communities with small gene pools, 
such as Amish and Ashkenazi Jews, and many of these groups have sought to ensure mixing 
occurs in order to protect the offspring.[27]  
2.2.1 Consequences of CM 
Marriage between related individuals can result in a number of adverse outcomes among their 
offspring. Stillbirth is a major concern and a metanalysis has shown that among first cousin 
marriages, a mean excess of 1.5% deaths.[22] A similar effect is seen in the number of infant 
deaths, with a mean 1.1% excessive deaths among first cousin offspring.[22] Consanguinity has 
also been shown to be associated with early childhood mortality. A 2001 study that analyzed the 
results of two nationally representative surveys. Using the 6,611 ever-married women ages 15 to 
49 from the Pakistan Demographic and Health Survey (PDHS) 1990-1991 and the 9,485 ever-
married Muslim women ages 13 to 49 who responded to the Indian National Family Health 
Survey (NFHS) 1992-1993, the investigators explored the association between first cousin 
marriages and early childhood mortality. As both surveys were designed by the same company, 
the sampling strategies and wording of the questions were very similar and allowed for ease of 
comparison. Overall, children born to first-cousin parents in India were at an increased risk of 
death during the neonatal period (OR: 1.3 (95% CI: 1.1-1.5)), post-neonatal period (OR: 1.2 
(95% CI: 1.1-1.5)), and infant period (OR: 1.2 (95% CI: 1.1-1.5)) compared to those born to non-
related parents. Additionally, children born to first-cousins were found to have an overall 
increased risk of death before the age of five (OR: 1.2 (95% CI: 1.0-1.4).[23] Results from 
analysis of the PDHS data were extremely similar, with the offspring of first cousins having an 
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increased risk of death during the neonatal period (OR: 1.3 (95% CI: 1.1-1.6), post-neonatal 
period (OR: 1.4 (95% CI: 1.2-1.8)), and infant period (OR: 1.3 (95% CI: 1.2-1.6)). Like the 
NFHS data, the PDHS analysis also showed an over increase in death before the age of five 
among children of first cousins compared to children of non-related parents.[23] Similar results 
were found in a study from Lebanon which showed a significant 1.8 fold increase in the risk of 
in-hospital mortality among the offspring of first cousin marriages compared to those of non-
related marriages. They also found a significant increase in the risk of preterm birth and birth of 
a low birth weight infant among those in first cousin marriages (p<0.001). [205] 
Interestingly, the overall fertility of consanguineous couples has been shown to be higher 
in the majority of studies.[22] It is unclear exactly why, but is possible that the increased fertility 
is to compensate for the higher number of losses.[22] However, it may also be due to younger 
age at marriage and resulting earlier first pregnancy.[24, 206, 207] 
The most common association with consanguineous marriage is congenital anomalies in 
the offspring. Generally, the risk is considered to be 1.7-2.8% higher among offspring of first 
cousin marriages than among those in non-consanguineous marriages. [24-26] Most of these 
conditions are autosomal recessive diseases.[26] Many rare genetic conditions are seen in 
populations with a high degree of inbreeding that are rarely seen among non-consanguineous 
couple offspring. [26, 204] In developed countries, populations known to have a high degree of 
inbreeding or to frequently carry recessive traits often seek screening and genetic counseling 
prior to conception. In less developed parts of the world, where the highest degrees of 
consanguinity are seen, these services are often unavailable and below par.[22, 27]  
 Identifying adverse outcomes of consanguineous marriage is important to provide 
evidence-based counseling guidelines for couples seeking assistance. It may also be important in 
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helping to determine other causes of these outcomes, especially in areas with high levels of 
consanguinity. Separating out the effects of CM and other potential risk factor will assist 
researchers in finding potential ways minimize risk both for those in related and non-related 
marriages. CM and spontaneous abortion 
2.2.1.1 Overview of spontaneous abortion 
Spontaneous abortion is defined as the spontaneous loss of a fetus before 20 weeks' gestation. It 
is generally estimated the approximately 15-20% of all pregnancies end in a spontaneous 
abortion. [208, 209] This number is underestimated because it does not include the large number 
of women who miscarry during the pre-clinical phase, the time before the woman recognizes that 
she is pregnant. These typically occur in the first few weeks of pregnancy and end around the 
time the women would normally expect her menstrual cycle. As such, estimating the true 
percentage of pregnancies that result in spontaneous abortions is difficult. Current literature 
estimates that an additional 30% of pregnancies may end during this early time period, bringing 
the total estimate of spontaneous loss up to 45-50%. [208, 209]  
Studying the causes of spontaneous abortion is extremely difficult. As previously 
discussed, many women do not have a recognized pregnancy prior to loss, so they are not 
included in most prospective studies, which often recruit women at a first prenatal visit. 
Prospective studies enrolling women in the pre-pregnancy stage are typically done on women 
receiving assisted reproductive technologies, such as IVF. [184-186] These women often have 
already experienced miscarriages or have been unable to become pregnant. Women undergoing 
assisted reproductive techniques are also from a higher socio-economic status than the general 
population. These issues may affect the overall generalizability of information gained from the 
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analysis. Further, even women who have a recognized pregnancy and know they are miscarrying 
do not always present to a hospital or a medical provider.  
While information on exact causes and mechanisms are still poorly understood, there are 
a number of known and hypothesized causes and risk factors. Chromosomal abnormalities play a 
role in roughly half of all spontaneous abortions. These losses usually occur during the early 
stages of pregnancy and may account for a large percentage of the preclinical losses 
experienced.[209] The longer a pregnancy lasts, the more likely the cause is unrelated to 
chromosomal abnormalities. A related risk factor is maternal age. Women over the age of 35 are 
at a greater risk of spontaneous abortion than younger women. Between ages 35 and 45 the risk 
nearly doubles and continues to increase steadily as the woman continues to age. By age 50, 
there is an 80% chance that a woman will miscarry.[208, 209] This increase can mostly be 
associated with the increase in fetal aneuploidy. However, older women are still at an increased 
risk of spontaneous abortion even controlling for chromosomal abnormalities. [209] The reasons 
for this elevated risk are still unknown, though some researchers theorize that an increased 
incidence of other medical conditions, such as endocrine disorders and uterine fibroids, at older 
ages may be partially to blame.[208] Other theories suggest that age effects oocyte quality and 
may also uterine senescence. [210-213] More research is needed in order to fully understand the 
reasons for this increased risk among older women. 
Another important consideration is environmental exposures. Lead, mercury, solvents, 
and radiation have all been associated with fetal loss. [214-222] In addition, smoking and second 
hand smoke may also as much as double a woman's chance of spontaneous abortion. [208, 209, 
223, 224] This same effect may also be seen for alcohol use. [208, 209] For both smoking and 
alcohol, the moderate increase in risk has only been shown in a few studies and data is limited on 
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whether this relationship may be due to these specific teratogens or to other confounding factors. 
Finally, other causal factors may include infection, maternal endocrine conditions, and 
pharmacological drugs. In general, more research is needed to determine the biological 
mechanism involved in each of these processes and to determine the overall risk incurred by 
women exposed to these factors. [209] 
2.2.1.2 Association between SAB and CM 
The majority of studies looking at consanguineous marriage and spontaneous abortion are cross-
sectional in nature. Often, women are asked about the nature of their relationship and then to 
recall their reproductive history. Studies examining this relationship have found differing results 
and no overall agreement has been reached. Several studies have reported a significant 
relationship between CM and spontaneous abortion. One case control study done in Oman 
looked at 141 miscarriages and compared the relatedness of the parents. 53% of cases were from 
consanguineous marriage and 42% were from non-consanguineous marriages. The remaining 
five percent were unknown.[225] No statistical comparisons were conducted to look at whether 
the difference in proportion were statistically significant; however, the authors did look at 
parental antibodies to see if there was a difference between the groups and found no statistically 
significant results.[225] A unique study in Nigeria looked at polygamous marriages that included 
both consanguineous and non-consanguineous unions. A total of 240 consanguineous couples 
and 229 non-consanguineous couples, for a total of 868 pregnancies, were utilized to compare 
rates of spontaneous abortion. Overall, the author found that spontaneous abortions were more 
than twice as common among consanguineous couples compared to non-consanguineous couples 
(p=0.01).[226]  
 55 
There are also a number of studies who have failed to show a relationship between 
consanguineous marriage and spontaneous abortion. A cross-sectional study of 920 ever-married 
Saudi women in the City of Dammam who had experienced at least one recognized pregnancy 
was performed to look at whether infant outcomes were affected by the relationship of the 
parents. Women were asked questions about prior births, stillbirths, and spontaneous abortion, in 
addition to their relation to their husband prior to marriage. Overall, 52.0% were in a 
consanguineous relationship. Second cousin relationships had the highest rate (85.8 per 1000), 
followed by double first cousins (83.7 per 1000), not related (80.1 per 1000), first cousins once 
removed (77.3 per 1000), distantly related (71.6 per 1000) and first cousins (65.6 per 1000). 
However, no statistically significant difference was found between the groups.[227] While the 
study had a high number of women in consanguineous marriages, the numbers in some of the 
relation groups are quite small, which may have affected their ability to obtain adequate power in 
their statistical test. Further, the study only enrolled women who had ever had a recognized 
pregnancy. Those women having spontaneous abortions before recognition were not included in 
this study, possibly slanting the results. Finally, all data collected in this study were based on 
self-report. Whether the women properly remembered the number of spontaneous abortions or 
accurately identified whether they had a spontaneous abortion or a still birth is unknown. In 
addition, women may intentionally underreport losses due to shame or other stigmas attached to 
the event. In addition, early pre-clinical losses would be missed, as women would be unaware of 
the event. [227] Al-Awadi et al. conducted a cross-sectional study with a representative 
population of 5,007 Kuwaiti females ages fifteen and older who presented to one of the nation’s 
sixteen gynecological clinics to determine whether consanguinity had an effect on prenatal and 
neonatal deaths. Their data showed an increase in the percent of abortions occurring in 
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consanguineous couples (12.04%) compared to non-consanguineous couples (11.70%), though 
this increase was non-significant and heavily swayed by the rate among first cousin relationships 
(12.44%).[228] Though this study was able to gain information on a large number of women in 
the population, it, like many studies, relied on self-reported data from women. Self-reported 
spontaneous abortion data has a number of issues associated with its use. First, women are only 
able to report recognized spontaneous abortions. Many women who have early miscarriages do 
not know they were pregnant and are therefore unaware of the loss. Second, the timing of the 
loss is often unknown. Inaccurate reporting of the gestational age at loss can result in 
misclassification bias. Finally, many women feel shame around spontaneous abortions and are 
unlikely to report the loss as part of a survey or interview.  
2.2.1.3 Studies of CM and SAB in India 
The majority of studies conducted on consanguineous marriage and reproductive outcomes have 
focused on the Middle East. Only five studies have reported on the effect of consanguinity in 
India on spontaneous abortion and stillbirth. The majority of existing data is drawn from cross-
sectional studies done over large areas. An early cross-sectional study examined the Kota, an 
isolated tribe living in the Nilgiri Hills of Tamil Nadu. This study examined 449 couples, with 
12.7% in consanguineous marriages. From both non-related and consanguineous pregnancies, 
roughly 8.3% reportedly ended in either spontaneous abortion or stillbirth. There was no 
difference between the two groups.[229] Another early cross-sectional study conducted in the 
North Arcot District of Tamil Nadu looked at the impact of consanguinity on fetal loss among 
women living in urban and rural areas.[230] A total of 20,626 women were interviewed, 
resulting in information on 70,161 pregnancies. Of these women, 46.9% were found to be in a 
consanguineous marriage, with the most common relation being first cousins, followed by uncle-
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niece relationships. Overall, the investigators found that in the rural area, the fetal loss rate was 
significantly higher among consanguineous couples (41.5 per 1000) than among non-
consanguineous couples (34.4 per 1000) (p<0.05). In urban areas, the opposite effect was seen, 
with non-consanguineous couples (70.9 per 1000) having a significantly higher rate of fetal loss 
than consanguineous couples (68.7 per 1000) (p<0.05). However, no consistent relationship was 
seen between degree of relatedness and rate of fetal loss. In the rural area, the highest rate of fetal 
loss was seen among uncle-niece marriages (45.0 per 1000), followed by beyond first cousins 
(43.0 per 1000), and first cousins (39.2 per 1000). In the urban area, the highest rate was among 
beyond first cousins relationships (78.7 per 1000), followed by uncle niece (74.0 per 1000), and 
first cousins (64.0 per 1000).[230] This study benefitted from direct interviews with a large 
population; however, the authors point out that the fetal losses captured in this data are almost all 
intermediate and late losses, occurring mostly after twenty weeks' gestation. As many 
miscarriages, especially those resulting from chromosomal abnormalities occur in the first ten 
weeks, the data contained in this study most likely underestimate the rate of fetal loss among all 
groups.  
A third cross-sectional study examined 377 marriages from the area near Vellore, Andhra 
Pradesh. Among the relationships examined 156 (41.4%) were consanguineous, with the most 
common relationship being first cousins (80), followed by uncle-niece (35). Among 
consanguineous couples, the rate of spontaneous abortion was 4.5 per 100 pregnancies, the rate 
of stillbirth 1.1 per 100 pregnancies, and the overall intra-uterine loss rate 5.6 per 100 
pregnancies. For non-consanguineous relationships, the rate of spontaneous abortion was 4.4 per 
100 pregnancies, the rate of still birth 2.1 per 100 pregnancies, and the overall intra-uterine loss 
was 6.5 per 100 pregnancies. There was no significant difference in the rates of spontaneous 
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abortion, stillbirth, or intra-uterine loss between consanguineous and non-consanguineous 
couples.[231] Though this study only sampled a small number of women, the rates they 
demonstrated were comparable to other rates reported for the region. While the authors do not 
mention any issues with recall bias, women were unlikely to report early spontaneous abortions, 
which may be more likely to occur among consanguineous couples than among those in non-
consanguineous marriages. A more recent case-control study in Pondicherry, looked at 1151 
pregnancies, 751 from consanguineous couples and 400 from non-consanguineous couples.[232] 
Of these, a total of 7.1% and 3.7% of the consanguineous couples' pregnancies ended in 
spontaneous abortion or still birth, respectively. By comparison, 6% of non-consanguineous 
couples' pregnancies ended in spontaneous abortion and 3.7% ended in stillbirth. There was no 
significant difference in the rates of either pregnancy outcome between these two groups.[232] 
This study benefitted from drawing on a database containing information on the relatedness of 
the parents' marriage. However, the sample was drawn largely for the purpose of examining 
congenital malformations. Therefore, a large portion of the sample was drawn from parents who 
had at least one live birth. The process of ascertaining information on spontaneous abortion and 
stillbirth is unclear and may be subject to recall bias. As with many studies, early spontaneous 
abortions may not be recognized or reported by women to interviewers, and, therefore, not 
included in the analysis.  
In contrast to earlier studies, a cross-sectional study utilizing data from the 1992 National 
Family Health Survey (NFHS) looked at data on miscarriage and consanguinity among 3,948 
women in Tamil Nadu, the India state with the highest rate of marrying relatives (48.2%).[233] 
This study found that as degree of relatedness increased so did the likelihood the woman had 
experienced a miscarriage (p=0.01). Using logistic regression they found that the odds of 
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pregnancy wastage was 1.3 times higher among women who married close relatives compared to 
women who married distant relatives or an unrelated person, controlling for age, childhood 
residence, religion, caste, education status, age at marriage, and age at first birth.[233] Like 
previous studies, this one is subject to recall bias, since all women are asked about past 
experiences. In addition, no data was collected on the degree of relatedness between the couple. 
Additionally, spontaneous abortion and stillbirth are grouped into the same category. 
All these studies required women to recall past experiences with spontaneous abortion 
and stillbirth. As women are unlikely to be aware of or report early spontaneous abortions, it is 
likely that all the captured data is from intermediate and late losses. Some studies group together 
all fetal loss, both spontaneous abortion and stillbirth, in order to look at total reproductive 
wastage. However, these two outcomes may result from different processes and consanguinity 
may not have the same effect on them (Table 9).  
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Table 9. Studies of CM and SAB in India 
Author 
(Year) 
N Study 
Design 
Population % in 
CM 
Results 
Ghosh, 
(1979) 
449 couples Cross-
sectional 
Tribe, Nilgiri 
Hills, Tamil 
Nadu 
12.7% NS* 
Rao (1979) 20,626 women 
(70,161 
pregnancies) 
Cross-
sectional 
North Arcot, 
Tamil Nadu 
46.9% Rural: 41.5 per 1000 
(CM) vs. 34.5 per 
1000 (NCM) 
(p<0.05) 
 
Urban: 68.7 per 1000 
(CM) vs. 70.9 per 
1000 (NCM) (p 
<0.05) 
Asha Bai 
(1981) 
377 women  Cross-
sectional 
Vellore, Andhra 
Pradesh 
41.4% 4.5 per 100 (CM) vs. 
4.4 per 100 (NCM) 
(NS) 
Jai (1993) 1,151 pregnancies Case 
control 
Pondicherry 
Region 
-- 7.1% (CM) vs. 6% 
(NCM) (NS) 
Sureender 
(1998) 
3,948 women Cross-
sectional 
Tamil Nadu 48.2% 1.3 % 
*No rate reported 
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3.0   THE LONGITUDINAL INDIAN FAMILY HEALTH STUDY 
The Longitudinal Indian Family Health (LIFE) Study is an ongoing collaborative project 
between the University of Pittsburgh and Science Health Allied Research Education (SHARE) 
India Research Foundation. Beginning in February of 2009, a pilot study was conducted to test 
protocols and procedures. This initial phase involved two of the forty villages in the Medchal 
Mandal region. Following completion of this test phase, recruitment for the full study began in 
the fall of 2010. Recruitment for the study was completed in August 2011. A total of 1,226 
women from 33 villages were enrolled in the study and completed the registration visit. Of those, 
932 (76.2%) are still being followed. The 294 women who are no longer being followed have 
been lost for a variety of reasons. A portion has been lost to follow-up or has moved away from 
the study villages. Others have declined further participation in the study. Finally, some women 
have opted for a sterilization procedure and are no longer eligible for the study. This can happen 
either before or after the woman has contributed a pregnancy to the study. Exact numbers for 
each of these categories are currently unavailable.  
 Study participants are contacted by staff at several time points before, during and after 
their pregnancy (Figure 1). After consent, participating men and women complete individual 
questionnaires that ask about social, behavioral, environment, and medical exposures that are of 
interest to study investigators. In addition, a household questionnaire is completed by one 
member of the couple to ascertain specific information about socio-economic status. Laboratory 
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sessions are scheduled for all participants. Women self-collect vaginal swabs, urine, and stool to 
return to the lab and have blood drawn by trained staff. Men self-collect urine and stool and also 
have their blood drawn by the lab team.  
After enrollment, women are re-interviewed monthly to ascertain the date of their last 
menstrual period (LMP). Staff time follow-up calls to fall after the expected date. If the woman 
has not had her menstrual cycle when the team member calls, they arrange a time for the field 
staff to meet her and perform a urine pregnancy test. If the test is negative, the woman is called 
again the next month. If the test is positive, the field staff schedules her first trimester visit, 
which includes another questionnaire about potential exposures and an extensive reproductive 
history. The same specimens are collected as at enrollment. Some women enter the study already 
pregnant, but not yet beyond the first trimester. In this case, both the registration and first 
trimester questionnaire are completed, but only one set of lab samples is collected.  
At the beginning of the third trimester, field staff contact the women and schedule the 
third trimester visit. This again consists of a questionnaire about potential exposures and 
collection of the same set of laboratory samples. If a woman loses a pregnancy before this time 
point or at any point during the pregnancy, a staff member interviews her and completes a 
pregnancy loss questionnaire that asks detailed questions about reason for loss, timing of loss, 
and potential risk factors.  
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Figure 1. LIFE Study Flow Chart 
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The ability to collect information at delivery is dependent on where the woman delivers. 
Roughly half of participants deliver at MediCiti Institute of Medical Sciences, where the study is 
housed. Sample collection is influenced by the length of labor and complications that arise. 
Ideally, urine, stool, blood, and vaginal samples are taken from all women. Meconium, cord 
blood, and stool are all collected from the infant and a sample of the placenta is sent to the 
histopathology laboratory to be examined for chorioamnionitis. A chart review form that 
includes information on delivery complications, health of the infant, health of the mother, and 
medications used is completed by the attending physician or trained nurse.  
Another visit is conducted at the end of the neonatal period, roughly 28 days after 
delivery. At this time, the same samples are again collected from the mother. A questionnaire is 
completed to ascertain information about the first few weeks of life. Further visits are being 
developed to continue to follow children through early life to study growth and development.  
Women who do not undergo sterilization and are not using birth control remain in the 
study and are followed closely by the staff to determine the ideal time point to resume collecting 
LMP data. This time is determined by a number of factors, including breastfeeding practices.  
 The LIFE study presents a unique opportunity to look at preconception and early 
pregnancy exposures which may influence reproductive outcomes. Unlike studies that enroll at a 
first prenatal visit, the study is actively recruiting pre-pregnant women. Further, these women are 
not considered a planning population, since they are not focusing on conceiving, thereby 
changing their behavior to prepare for pregnancy. Finally, time to pregnancy in this population is 
short, ensuring that out sample size is large enough to gather the number of pregnancies 
necessary to look at these outcomes in a relatively brief period of time. Many pregnancy studies 
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done are conducted in developed countries, which provide little knowledge about some of the 
potentially unique and important exposures which are only found in the developing world. This 
study will provide data to inform future studies and develop public health interventions to reduce 
the rates of adverse outcomes in an area where the overall prevalence is high.  
 
 
 66 
4.0  MANUSCRIPT 1: COMPARISON OF LABORATORY METHODS FOR 
IDENTIFICATION OF BACTERIAL VAGINOSIS 
Manuscript in Preparation 
 
Jamie M. Eastman, MPH1, Kalpana Basany2, MD, Clareann H. Bunker, PhD1, Gong Tang, PhD3, 
and Catherine L. Haggerty, PhD, MPH1,4.  
 
 
1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 
Pittsburgh, PA  
2SHARE INDIA, MediCiti Institute of Medical Sciences, Ghanpur, India 
3Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, 
Pittsburgh, PA 
4Magee-Womens Research Institute, Pittsburgh, PA 
 
 
 
 67 
4.1 ABSTRACT 
Background: Bacterial vaginosis (BV) is a common reproductive condition among women of 
childbearing age. Left untreated, BV can lead to serious reproductive sequelae and adverse birth 
outcomes. At MediCiti Institute of Medical Science (MIMS) in Ghanpur, Andhra Pradesh, India, 
the presence of clue cells in Gram stained vaginal slides as a sole criterion to diagnose BV is 
common in both clinical practice and research. We sought to determine whether this was a 
sensitive and specific way of testing for BV compared to Nugent’s criteria. 
Methods: Self-collected vaginal slides were collected from 883 women ages 15-35 enrolled in 
the Longitudinal Indian Family Health (LIFE) Study. Samples were Gram stained and analyzed 
for clue cells by trained laboratory staff at the Central Laboratory at MIMS. A second trained 
reviewer read the slides using Nugent’s criteria, a quantitative laboratory method of diagnosing 
BV using Gram stained slides made from vaginal samples. Demographic characteristics of the 
population were calculated and compared using a t-test for continuous variables and chi-square 
test for categorical variables. Sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) were calculated for the comparison between the two methods of 
BV diagnosis and agreement between the approaches was examined using the kappa statistic. 
Women were stratified by pregnancy status, time since last menstrual period, religion, and age to 
determine if differences existed in the agreement between the two methods of BV diagnosis.  
Results: A total of 883 vaginal slides were analyzed. Prevalence of BV using clue cell analysis 
was 21.7% (95% CI: 19.0-24.5% ) compared to 13.9% (95%CI: 11.6-16.2% ) using Nugent’s 
criteria. Clue cell analysis had a sensitivity of 39.8% (95% CI: 36.6-43.0%), specificity of 81.2% 
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(78.6-83.8%), PPV of 25.5% (95% CI: 22.7-28.4%) and NPV of 89.3% (95% CI: 87.3-91.3%) 
for the diagnosis of BV using Nugent’s criteria. 
Discussion: Clue cell analysis is an insufficient way to diagnose BV among childbearing age 
women. Using this method, a large proportion of the cases will be missed, potentially leading to 
misclassification in research studies and to serious reproductive outcomes in patient settings. 
Nugent’s criteria, the current gold standard for BV diagnosis in research, is preferable.  
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4.2 BACKGROUND 
Bacterial vaginosis (BV) is the most common vaginal infection among women of childbearing 
age. In the United States, the prevalence has been found to be 30%.[32] No population studies 
have been done in India, but studies have estimated that up to 39% of childbearing age women 
are affected.[4, 5]  Left untreated, BV may lead to serious reproductive sequelae, including 
pelvic inflammatory disease (PID), [13-17] cervicitis [8, 10-12] and infertility. [16, 53-55] 
Among pregnant women, BV infection has been associated with adverse reproductive outcomes 
such as spontaneous abortion [20, 70, 174, 176] and preterm birth.[88, 193, 194] As up to 80% 
of women with BV may be asymptomatic,[32] identification of infected women can be 
challenging, especially in resource poor settings. 
Amsel’s criteria are the clinical standard for diagnosis and requires that the patient meet 
three out of four of the following criteria: clue cells present on >20% of epithelial cells, vaginal 
pH >4.5, positive amine and abnormal discharge. [62]  In practice, the full criteria are often not 
examined by providers, leading to a number of cases being missed, even in developed countries. 
[66] For the purposes of research, Nugent’s criteria are considered the gold standard for 
laboratory diagnosis. This standardized method involves quantitative scoring of three bacteria 
morphotypes, resulting in a score ranging from zero to 10. Women who receive scores of zero to 
three are considered normal, those who receive scores of four to six are classified as intermediate 
and those with scores of seven to 10 are considered to have BV. [71] This method has been 
found to have high sensitivity and specificity, as well as high inter- and intra-rater reliability. 
[72-74, 76] 
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A number of studies have examined the potential use of a limited set of Amsel’s criteria 
or a combination of two criteria. Studies that have compared the identification of clue cells as a 
sole method to diagnose BV (termed clue cell analysis herein) to Nugent’s criteria have found 
mixed results, with sensitivities ranging from 39.5-100.0% and specificities ranging from 76.0-
97.0%. [34, 122, 128, 234-236] In developing countries, gynecological departments are often 
overburdened with women from the surrounding villages. Clue cell analysis is a fast and 
relatively inexpensive method of distinguishing women with BV from those without. Unlike 
Nugent’s criteria, it does not require any specialized training and can be performed by most of 
the laboratory personnel. However, it is possible that relying upon using clue cell analysis 
misdiagnoses a number of cases that should be referred for additional care and treatment. We 
sought to determine the accuracy of using the presence of clue cells analysis for the diagnosis of 
BV in a rural South Indian population using Nugent’s criteria as the gold standard. 
4.3 METHODS 
This study was conducted in the Central Laboratory at MediCiti Institute of Medical Sciences 
(MIMS) in Ghanpur, Andhra Pradesh, India, using vaginal samples collected at enrollment from 
women enrolled in the Longitudinal Indian Family Health (LIFE) study (n=1,226). Briefly, the 
LIFE Study is a longitudinal cohort study designed to study the risk factors for low birth weight 
among a rural South Indian population. Women were eligible to participate if they were married, 
living in one of the Medchal Mandal villages served by MIMS, not currently pregnant or <14 
weeks’ gestation and between the ages of 15-35. Women were excluded if either they or their 
partner had undergone a sterilization procedure, they were not planning on having any more 
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children or if they lived in one of the two villages with a highly transient population. At 
enrollment, women provided informed consent, completed a questionnaire about their current 
health status, and provided urine, blood, stool and vaginal samples. The LIFE study has been 
approved by the SHARE India Ethics committee at MIMS, Ghanpur, Andhra Pradesh, India and 
by the Institutional Review board at the University of Pittsburgh, Pittsburgh, PA, U.S.A.  
4.3.1 Ascertainment of Demographic Information 
For stratification purposes, women were considered to have been pregnant at the time of 
registration if they either self-reported being pregnant or had a positive urine pregnancy test at 
the time of enrollment. Women who were not pregnant at the time of enrollment were divided 
into two groups based on LMP, those who reported their LMP as <7 days prior to sample 
collection and those who reported their LMP as >7 days prior to sample collection. Laboratory 
collection was normally done within one week of women completing the questionnaire. Religion 
was self-reported and divided into three groups: Hindu, Muslim, and other.  
4.3.2 Laboratory Methods 
Vaginal samples were self-collected by women and provided to the laboratory staff. Self-
collection swabs have been shown in previous studies to have high sensitivity and specificity 
compared to provider-collected swabs for diagnosis of BV. [81-85] Vaginal samples collected at 
enrollment were Gram stained and analyzed for presence of clue cells at 400x magnification by 
trained laboratory microbiologists in the Central Laboratory. A separate trained reviewer blinded 
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to the results of the clue cell analysis read the slides under 1000x magnification and quantified 
the morphotypes using Nugent’s criteria.[71]   
4.3.3 Statistical Analysis 
Two comparisons of the diagnostic methods were performed. We compared women with BV by 
Nugent’s criteria (scores 7-10) to women without BV (scores 0-6) compared to clue cell 
diagnosis. Second, we compared women with abnormal flora (scores 4-10) compared to women 
with normal flora (scores 0-3). Diagnosis of BV using clue cells was compared with the results 
of the Nugent scoring, which was considered the gold standard. Sensitivity and specificity, with 
95% confidence intervals (95% CI), were calculated. Positive predictive values (PPV) and 
negative predictive values (NPP) were also calculated. A kappa value for agreement between the 
two methods of scoring was also calculated and assessed using the standard criteria. Stratified 
analysis was performed for variables that could potentially influence the accuracy of the results. 
Specifically, pregnancy status, age, self-reported last menstrual period (LMP) <7 days prior to 
swab collection. 
4.4 RESULTS 
4.4.1 Characteristics of the study population 
A total of 883 slides were read analyzed using both Nugent’s criteria and clue cell analysis. Non-
pregnant women made up 78.7% of the sample (n=695). The majority, 89.2%, of women 
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reported their religion as Hindu (n=788), with 6.0% reporting their religion as Muslim (n=53) 
and 4.8% reporting another or no religion (n=42). Prevalence of BV using clue cell analysis was 
21.7% (95% CI: 19.0-24.5%). The prevalence was slightly higher among non-pregnant women 
(23.2%; 95% CI: 20.0-26.3%) compared to pregnant women (16.49%; 95% CI: 11.1-21.8%). 
Using Nugent scoring, the prevalence of BV was 13.9% (95%CI: 11.6-16.2%), with higher 
prevalence found among non-pregnant women (15.25%; 95%CI: 12.6-17.9%) than pregnant 
women (9.04%; 95% CI: 86.2-94.6%). Abnormal flora (Nugent scores 4-10) was also common 
in our population, with a prevalence of 30.12% (95% CI: 27.1-33.1%) among the entire 
population, and similar rates among the pregnant (29.25%; 95% CI: 22.7-38.8%) and non-
pregnant (30.36%; 95% CI: 26.9-33.8%) women (Table 13).  
4.4.2 Comparison of diagnosis by clue cell analysis to Nugent’s criteria 
Compared to Nugent’s criteria, clue cell analysis had a sensitivity of 39.8% (95% CI: 36.6-
43.0%), specificity of 81.2% (78.6-83.8%), PPV of 25.5% (95% CI: 22.7-28.4%) and NPV of 
89.3% (95% CI: 87.3-91.3%)(Table 14). The kappa statistic for the agreement between the two 
methods was 0.17, indicating low agreement (p<0.001). When diagnosis by clue cells analysis 
was compared to abnormal flora or normal flora by Nugent’s criteria the sensitivity decreased to 
31.2% (95% CI: 28.1-34.3%), and specificity remained similar (82.3%; 95% CI: 79.8-84.8). The 
PPV value increased to 43.2% (95% CI: 39.9-46.5%) and the NPV decreased to 73.5% (95% CI: 
70.5-76.4%). The kappa statistic for agreement between these methods was 0.15, indicating low 
agreement (p<0.001) (Table 14). 
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4.4.3 Stratification by pregnancy status 
When women were stratified by pregnancy status, the sensitivity of clue cell analysis compared 
to BV or no BV by Nugent’s criteria for the diagnosis of BV among non-pregnant women was 
41.5% (95% CI 37.8-45.2%). Clue cell analysis had a specificity of 80.1% (95%: 77.1-83.1%), 
PPV of 27.3% (95% CI: 24.0-30.6%) and NPV of 88.4% (95% CI: 86.0-90.8%). The kappa 
value for agreement between methods was 0.18, indicating low agreement. For pregnant women, 
the sensitivity of the clue cell analysis compared to Nugent’s criteria was significantly lower 
(29.4%; 95% CI: 22.9-35.9%), as was the PPV (16.1%; 95% CI: 10.8-21.4%). Specificity 
(84.8%; 95% CI: 79.7-89.9%) and the NPV (92.4%; 95% CI: 88.6-96.2%) were similar. The 
kappa value for the agreement between methods was 0.10, indicating low agreement. Among 
non-pregnant women when diagnosis by clue cell analysis was compared to diagnosis of 
abnormal flora by Nugent’s criteria the sensitivity was 33.2% (95% CI: 29.7-36.7%), the 
specificity was 81.2% (95% CI: 78.3-84.1%), the PPV was 43.5% (95% CI: 39.8-47.2%) and the 
NPV was 73.6% (95% CI: 70.2-76.9%). Among the pregnant women, the values were similar, 
with sensitivity of 23.6% (95% CI: 17.5-29.7%), specificity of 86.5% (95% CI: 81.6-91.4%), 
PPV of 41.9% (95% CI: 34.8-49.0%) and NPV of 73.2% (95% CI: 66.9-79.5%). The kappa 
value for agreement between the two methods was 0.12, indicating low agreement. When the 
area beneath the ROC curve was compared between the two groups the difference was not 
significant for either the comparison of diagnosis by clue cells to diagnosis of BV by Nugent’s 
criteria (p=0.56) or for the comparison between diagnosis by clue cell to diagnosis of abnormal 
flora by Nugent’s criteria (p=0.57) (Table 15).  
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4.4.4 Stratification by LMP<7 days prior to collection 
Among women who reported their LMP date as >7 days prior to vaginal swab collection the 
sensitivity of clue cell analysis compared to Nugent’s criteria was 40.4% (95% CI: 36.4-44.4%), 
specificity was 80.1% (95%CI: 76.8-83.3%, PPV was 26.7% (95% CI: 23.1-30.3%), and the 
NPV was 88.3% (95% CI: 85.7-90.9%). The kappa value for agreement between the two 
methods was 0.17, indicating low agreement. Similar values for sensitivity (47.1%; 95% CI: 
37.7-56.5%), specificity (80.2%; 95% CI: 72.7-87.7%), PPV (30.8%; 95% CI: 22.1-39.5%) and 
NPV (89.0% ; 95% CI: 83.1-94.9%) were found among women who reported their LMP to be <7 
days prior to vaginal swab collection.  The kappa value for the comparison between the two 
methods indicated low agreement (kappa=0.22)(Table 16).  
Additional analysis comparing clue cells analysis to diagnosis of abnormal vaginal flora 
by Nugent’s criteria showed the sensitivity to be 33.7% (95% CI: 29.9-37.5%), specificity to be 
81.4% (95% CI: 78.3-84.5%), PPV to be 43.0% (95% CI: 39.0-47.0%) and the NPV to be 74.8% 
(95% CI: 71.4-78.3%) among women reporting their LMP as >7 days prior to collection of the 
vaginal swab. Overall agreement between the two methods was low (kappa=0.17). Among 
women who reported their LMP as <7 days prior to collection of the vaginal swab showed 
similar sensitivity(30.8% ; 95% CI: 22.1-39.5%), specificity (79.7%; 95% CI: 72.1-87.3%), PPV 
(46.2% ; 95% CI: 36.8-55.6%) and NPV (67.1%; 95% CI: 58.2-76.0) for the comparison 
between diagnosis by clue cells and diagnosis as abnormal vaginal flora by Nugent’s criteria. 
Agreement between these two methods for this group was also low (kappa=0.11).  
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4.4.5 Stratification by religion 
The sensitivity of diagnosis of clue cells compared to diagnosis of BV by Nugent’s criteria was 
significantly higher among Hindus (43.0%; 95% CI: 39.5-46.5%) compared to Muslims (16.7%; 
6.7-26.7%) and to women categorized as other (25.0%; 95% CI: 12.1-37.9%). The specificity 
was 80.5% (95% CI: 77.7-83.3%) among Hindus, 90.2% (95% CI: 82.2-98.2%) among Muslims, 
and 84.2% (95% CI: 73.3-95.1%) among the other group. Similar results were seen for the PPV 
(Hindu: 25.7%; 95% CI: 22.6-28.8%; Muslim: 33.3%; 95% CI: 20.6-46.0%; Other: 91.4%; 95% 
CI: 83.0-99.8%) and NPV (Hindu: 90.0%; 95% CI: 87.9-92.1%; Muslim 78.7%; 95% CI: 67.7-
89.7%; Other: 91.4%; 95% CI: 83.0-99.8%). Agreement between methods for all religious 
groups was the low (Hindu: 0.18; Muslim: 0.08; Other: 0.07) (Table 17). 
Sensitivity of clue cell analysis compared to Nugent’s criteria for diagnosis of abnormal 
flora was lower among Muslims (14.3%; 95% CI: 5.9-23.7%) and those of other religious 
orientation (30.0%; 95% CI: 16.1-43.9%) as compared to Hindus (32.8%; 95% CI: 29.5-36.1%). 
However, the other group was not significantly different (30.0%; 95% CI: 16.1-43.9). Specificity 
of clue cell analysis was similar among Hindus (81.6%; 95% CI: 78.9-84.3%), Muslims (90.6%; 
95% CI: 82.7-98.5%), and women categorized as other (87.5% ; 95% CI: 77.5-97.5%). Similar 
results were also found for the PPV and NPV (Table 17). Agreement between the methods was 
low for Hindus (kappa=0.15), Muslims (kappa=0.06) and the other group (kappa=0.20). 
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4.5 DISCUSSION 
This study has shown that use of clue cells alone as a diagnostic test for BV in a rural Indian 
setting is inadequate compared to the gold standard, Nugent’s criteria. While the specificity of 
the test is reasonably high, the sensitivity is too low to be considered useful in identifying 
women who should be treated.  
The ability of clue cell analysis to diagnose BV correctly was most influenced by 
pregnancy status. Clue cell analysis was significantly more sensitive (41.5%; 95% CI 37.8-
45.2%) among women who were not pregnant than among women who were pregnant (29.4%; 
95% CI 22.9-35.9%) when compared to diagnosis of BV by Nugent’s criteria (scores 7-10). 
Increased cervical mucus among pregnant women may make identification of clue cells more 
difficult. [237] We also found that clue cell analysis is more sensitive for diagnosis of BV among 
Hindus (43.0%95% CI 39.5-46.5%) than Muslims (16.7%; 95% CI 6.7-26.7%) when compared 
to diagnosis of BV by Nugent’s criteria. Unmeasured cultural factors that influence vaginal flora, 
such as douching and ritualistic bathing rituals,[238] may create slides with few bacteria. Though 
the remaining bacteria can be accounted for with Nugent’s criteria, it would result no clue cells.  
Our study had several strengths. First, we had a large sample of women for comparison 
of methods, which allowed adequate power to stratify by a number of variables that were 
hypothesized to potentially alter the diagnostic capability of the test. Second, we were able to use 
the laboratory at the hospital that serves most of the population from which the participants in 
our study were enrolled. Use of clue cell analysis for identification and diagnosis of BV is 
common in this setting for both research and clinical purposes. This study allowed us to compare 
clue cell analysis to the gold standard test for BV in order to determine whether the laboratory’s 
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clue cell classification is sufficient for continued use in research studies conducted in 
underdeveloped countries.  
We did not have a measure of whether women had signs and symptoms of BV at the time 
of vaginal swab collection. Other studies have found that use of a single criterion from Amsel’s 
method of diagnosis is more sensitive and specific among symptomatic women than among 
asymptomatic women. In addition, we were unable to compare the results of the clue cell 
analysis to a full clinical diagnosis by Amsel’s criteria. However, studies have shown that 
Nugent’s criteria is highly sensitive (89.1%) and sensitive (83.1%).[72]  
This study suggests that while diagnosis of BV using clue cells analysis would avoid 
referring a large number of negative women for treatment, it would miss diagnosing a high 
percentage of positive patients. This is especially concerning in childbearing age women who are 
planning on becoming pregnant in the near future. Considering that effective and safe treatments 
for non-pregnant women are available in resource poor settings, identifying and treating women 
prior to conception should be an important part of their gynecological care and may assist in 
preventing adverse birth outcomes that are common in this population. For this reason, clue cell 
analysis should be considered an inadequate method for the diagnosis of BV and either Amsel’s 
or Nugent’s criteria should be utilized in clinical treatment and research in both developed and 
developing countries.  
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4.6 TABLES 
 
Table 10. Comparison of Nugent scoring results to clue cell analysis 
 
 Nugent’s Score 
Normal 
(scores 0-3) 
Int. 
(scores 4-6) 
BV 
(scores 7-10) 
Total 
No clue cells  508 (73.5) 109 (15.8) 74 (10.7) 691 (78.3) 
Clue cells 109 (56.8) 34 (17.7) 49 (25.5) 192 (21.7) 
Total 617 (69.9) 143 (16.2) 123 (13.9) 883 (100.0) 
 
Table 11. Overall agreement between two diagnostic measures 
 
 Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV3 
(95% CI) 
NPV4 
(95% CI) 
Kappa 
Clue Cells 
compared to 
BV vs. no BV1 
39.8%  
(36.6-43.0%) 
81.2%  
(78.6-83.8%) 
25.5%  
(22.7-28.4%) 
89.3%  
(87.3-91.3) 
0.1702* 
Clue Cells 
compared to 
abnormal vs. 
normal flora2 
31.2%  
(28.1-34.3%) 
82.3%  
(79.8-84.8%) 
43.2%  
(39.9-46.5%) 
73.5%  
(70.6-76.4%) 
0.1470* 
1 Comparison of Nugent scores 0-6 vs. 7-10 
2 Comparison of Nugent scores 0-3 vs. 4-10 
3Positive Predictive Value 
4 Negative Predictive Value 
*p<0.001 
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Table 12. Agreement between two diagnostic measures by pregnancy status 
 Pregnancy 
Status 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV 
(95% CI) 
NPV 
(95% CI) 
Kappa 
Clue Cells 
compared to 
BV vs. no 
BV1 
Non-pregnant 
(n=695) 
41.5%  
(37.8-45.2%) 
80.1%  
(77.1-83.1%) 
27.3%  
(24.0-30.6%) 
88.4%  
(86.0-90.8%) 
0.185 
Pregnant 
(n=188) 
29.4%  
(22.9-35.9%) 
84.8%  
(79.7-89.9%) 
16.1%  
(10.8-21.4%) 
92.4%  
(88.6-96.2%) 
0.106 
Clue Cells 
compared to 
abnormal vs. 
normal flora2 
Non-pregnant 
(n=695) 
33.2%  
(29.7-36.7%) 
81.2% 
(78.3-84.1%) 
43.5%  
(39.8-47.2%) 
73.6%  
(70.2-76.9%) 
0.155 
Pregnant 
(n=188) 
23.6%  
(17.5-29.7%) 
86.5%  
(81.6-91.4%) 
41.9%  
(34.8-49.0%) 
73.2%  
(66.9-79.5%) 
0.127 
1 Comparison of Nugent scores 0-6 vs. 7-10 
2 Comparison of Nugent scores 0-3 vs. 4-10 
3Positive Predictive Value 
4 Negative Predictive Value 
5p<0.001 
6p=0.07 
7p=0.04 
 
 
 
Table 13. Agreement of diagnostic methods by time since LMP 
 Time since 
LMP 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV 
(95% CI) 
NPV 
(95% CI) 
Kappa 
Clue Cells 
compared to 
BV vs. no 
BV1 
>7 days prior 
to test date 
(n=587) 
40.4%  
(36.4-44.4%) 
80.1%  
(76.8-83.3%) 
26.7%  
(23.1-30.3%) 
88.3%  
(85.7-90.9%) 
0.175 
<7 days prior 
to test date 
(n=108) 
47.1%  
(37.7-56.5%) 
80.2%  
(72.7-87.7%) 
30.8%  
(22.1-39.5%) 
89.0%  
(83.1-94.9%) 
0.226 
Clue Cells 
compared to 
abnormal vs. 
normal flora2 
>7 days prior 
to test date 
(n=587) 
33.7%  
(29.9-37.5%) 
81.4%  
(78.3-84.5%) 
43.0%  
(39.0-47.0%) 
74.8%  
(71.4-78.3%) 
0.165 
<7 days prior 
to test date 
(n=108) 
30.8%  
(22.1-39.5%) 
79.7%  
(72.1-87.3%) 
46.2%  
(36.8-55.6%) 
67.1%  
(58.2-76.0%) 
0.117 
1 Comparison of Nugent scores 0-6 vs. 7-10 
2 Comparison of Nugent scores 0-3 vs. 4-10 
3Positive Predictive Value 
4 Negative Predictive Value 
5p<0.001 
6p=0.0079 
7p=0.1106 
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Table 14. Agreement of diagnostic methods by religion 
 Religion Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV 
(95% CI) 
NPV 
(95% CI) 
Kappa 
Clue Cells 
compared to 
BV vs. no 
BV1 
Hindu  
(n=788) 
43.0%  
(39.5-46.5%) 
80.5% 
(77.7-83.3%) 
25.7%  
(22.6-28.8%) 
90.0%  
(87.9-92.1%) 
0.18 
Muslim  
(n=53) 
16.7%  
(6.7-26.7%) 
90.2%  
(82.2-98.2%) 
33.3%  
(20.6-46.0%) 
78.7%  
(67.7-89.7%) 
0.08 
Other  
(n=42) 
25.0%  
(12.1-37.9%) 
84.2 % 
(73.3-95.1%) 
14.3%  
(3.8-24.8%) 
91.4%  
(83.0-99.8%) 
0.07 
Clue Cells 
compared to 
abnormal vs. 
normal flora2 
Hindu  
(n=788) 
32.8% 
(29.5-36.1) 
81.6% 
(78.9-84.3) 
43.1% 
(39.6-46.6) 
74.1% 
(71.0-77.2) 
0.15 
 
Muslim  
(n=53) 
14.3% 
(5.9-23.7) 
90.6% 
(82.7-98.5) 
50.0% 
(46.7-73.1) 
61.7% 
(48.6-74.8) 
0.06 
Other  
(n=42) 
30.0% 
(16.1-43.9) 
87.5% 
(77.5-97.5) 
42.9% 
(27.9-57.9) 
80.0% 
(67.9-92.1) 
0.20 
1 Comparison of Nugent scores 0-6 vs. 7-10 
2 Comparison of Nugent scores 0-3 vs. 4-10 
3Positive Predictive Value 
4 Negative Predictive Value 
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5.1 ABSTRACT 
Background: Bacterial vaginosis (BV) is a common vaginal infection among childbearing age 
women around the world. Risk factors for this infection are not well understood and may vary 
between populations. To date, no studies in India have examined a wide range of potential risk 
factors to look for associations with BV. Identification of potential factors would provide 
valuable information for screening and treatment programs.  
Methods: We explored a series of potential risk factors among 658 non-pregnant and 173 
pregnant women in rural India. Exposure data was ascertained through an interview with woman 
done at enrollment visits conducted between October 2009 and August 2011. BV status was 
ascertained by Nugent’s criteria on Gram-stained slides made from self-collected vaginal swabs 
taken at the same time as the interview. To determine association with BV, crude odds ratios 
(OR) and 95% confidence intervals (CI) were calculated using logistic regression for each 
individual risk factor. Factors that were independently associated with BV at p<0.25 were 
considered for the adjusted analysis.  
Results: Women who reported drinking tap water were more likely to have BV than women who 
reported drinking purchased water (ORadj 1.4; 95% CI 0.9-2.0),.though the increase was non-
significant. Non-significant increases in the odds of having BV were also seen for Muslims 
compared to Hindus (ORadj 1.8; 95% CI 0.9-3.6).  
Discussion: Among rural women in Medchal Mandal, no significant risk factors for BV were 
found. However, Muslim women and those who reported drinking tap water were more likely to 
 84 
have BV at baseline. These trends warrant further investigation into the mechanisms behind 
these increases in order to inform public health screening programs. 
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5.2 INTRODUCTION 
Bacterial vaginosis (BV) is characterized by a change in the normal vaginal flora from a majority 
of lactobacilli to a mix of anaerobes, Gardnerella vaginalis, and Mycoplasma hominis. [28] In 
the United States, BV is the most common vaginal infection, affecting roughly 30% of 
childbearing age women. [32] Fewer studies have been done in India to determine the prevalence 
and those that have been done report ranges from 4.5-64%. [34, 119, 120, 122-129] Importantly, 
these studies have been done mainly in large cities and have focused on high risk populations, 
such as sex workers or those individuals reporting to sexually transmitted infection (STI) clinics. 
Untreated, women with BV can develop pelvic inflammatory disease, endometritis,[6-9] 
cervicitis, [8, 10-12] and pelvic inflammatory disease. [13-17] Women with BV have also been 
shown to be more susceptible to developing sexually transmitted infections (STIs) such as 
Chlamydia, gonorrhea, and HIV. [56-59] In addition, BV has been associated with an increased 
risk of spontaneous abortion, preterm birth, low birth weight, and chorioamnionitis. [7, 11, 18, 
19] Early identification and treatment of BV can prevent adverse outcomes, with standard 
treatment curing up to 70% of patients.[91, 156]  
As early detection and treatment of BV is important for the prevention of sequelae, the 
identification of women at highest risk who could benefit the most from screening is important.  
However, the risk profile of BV remains unclear.[28, 36, 37] Though many studies have shown 
that sexual practices such as number of partners [130, 133] and use of condoms [132, 134, 139, 
142] play a role in the development of infection, BV is not considered a sexually transmitted 
 86 
infection and has been found among virginal women.[155]  Numerous studies have shown 
several non-sexual risk factors to also play a key role in the development of BV. Evidence points 
toward factors such as douching,[52, 131, 135, 152, 169] stress level,[48, 50, 151] smoking,[45, 
150] and hygiene. [147-149] However, there are an equal number of studies who have found no 
relationship between these risk factors and BV.[31, 42, 44, 52] Further research is needed to 
determine which factors may be key in development of BV, keeping in mind that underlying 
demographic and behavioral attributes of a population may impact which are most important.   
As very few studies have examined risk factors for BV among Indian women,[124, 239] 
we sought to determine the population-based prevalence and risk factors for BV in rural Andhra 
Pradesh, India. Based on our knowledge of the area, we hypothesize that women with BV will be 
more likely to belong to a lower caste, have less education, report douching, report previous 
vaginal infections, and use tap water.  
5.3 METHODS 
5.3.1 Study design 
The Longitudinal Indian Family hEalth (LIFE) Study enrolled 1,226 married women aged 15-35 
from October 2009 through August 2011. Women and their husbands were eligible to participate 
if they lived in one of the non-transient villages that make up Medchal Mandal, were planning on 
having more children, neither partner was sterilized, and the woman was not currently pregnant 
beyond the first trimester. Husbands of potential participants were encouraged to participate in 
the study as well. Informed consent was obtained from all participants at the time of registration. 
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If the woman was under the age of eighteen, her husband was required to legally consent for her 
to participate and the woman provided assent.  
At baseline, women were asked a series of questions about their demographics, current 
health status, and behavior, including questions about tobacco and alcohol consumption, water 
and sanitation, date of last menstrual period (LMP) and hygiene. Women were asked at 
enrollment whether they thought they were pregnant. Women who thought they might be 
pregnant were given a urine pregnancy test to confirm. For women who reported they were not 
pregnant or were unsure, data on the date of the participant’s LMP were obtained. When women 
either could not remember or were more than five weeks post LMP, a urine pregnancy test was 
done to determine their status.  
Women were also asked to provide blood, urine, stool, and vaginal samples for analysis. 
Vaginal samples were obtained using self-collection kits provided to enrolled participants. 
Trained field staff demonstrated the technique and reviewed the instructions with participants. 
Previous research has shown self-collected vaginal swabs to have a high sensitivity and 
specificity compared to provider-collected swabs when analyzed for BV. [82-86] Women 
collected the sample using a Dacron swab and returned the specimen to laboratory personnel in 
the field.  
5.3.2 Laboratory Analysis 
Gram-stained slides were made from vaginal samples and numbered using the participant’s 
assigned study identification number. Slides were then read by a single observer (JE) using 
Nugent’s criteria.[71] Women were identified as having BV if they had a score of 7-10. Normal 
flora was defined as a score of 0-3 and intermediate bacteria defined as a score of 4-6. The reader 
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was blinded to the participants’ characteristics and responses to interview questions. This study 
protocol was approved by the Ethics Committee of the MediCiti Institute of Medical Sciences 
and the Institutional Review Board at the University of Pittsburgh.  
5.3.3 Statistical analysis 
Prevalence of BV and corresponding 95% confidence intervals were calculated in pregnant and 
non-pregnant women. Baseline characteristics, including age, caste, religion, employment, 
educational attainment, depressive symptoms, douching habits, water source, past vaginal 
infection, and recent urinary tract infection were compared between BV positive and negative 
women using the X2 test of proportions.  Fisher’s exact test was substituted where necessary due 
to small expected values. Further stratification was done by pregnancy status and baseline 
characteristics reexamined. Risk factors were first examined using crude odds ratios and 95% 
confidence intervals. Women with BV (scores 7-10) were compared to women with normal flora 
(scores 0-3) and to women with either normal or intermediate flora (0-6). In addition, women 
with abnormal flora (scores 4-10) were compared to women with normal flora (scores 0-3).  
Variables that were significant (p<.25) in the univariate analysis in any of the models of BV or 
abnormal flora (p<.25) were included in the multivariable logistic regression model along with 
variables that were determined a priori to be important based on previously published literature 
and knowledge of cultural practices. Data were analyzed using Stata 12. [240] 
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5.4 RESULTS 
 
5.4.1 Population characteristics 
A total of 898 women had vaginal samples with Nugent scores from registration, 658 from 
women who enrolled pre-pregnancy and 173 who enrolled in their first trimester. At the time the 
questionnaire was administered (Table 18), women reported a mean age of 21.0 years, rated their 
health as very good or good (85.6%) and did not report depressive symptoms (94.2%) using the 
criteria established by Jeyabalan et al.[241] Participants were mostly Hindu (89.2%), belonged 
to a backward caste (53.2%), had a primary level education (61.3%), did not work outside of 
their home (75.4%), and bought canned drinking water (66.3%). About a quarter of women 
(26.8%) self-reported ever having a previous vaginal infection based on symptomology. Few 
women reported having a urinary tract infection in the previous 30 days (3.7%) or reported 
having ever douched (4.2%). At baseline, women who were pregnant had similar characteristics 
compared to women who were not pregnant (data not shown). Only education level was 
significantly different between the two groups, with pregnant women having a higher level of 
attainment (p=0.006). 
5.4.2 Prevalence of BV 
The overall prevalence of BV in our study was 14.1% (95% CI 11.9-16.4%), with a higher 
prevalence among non-pregnant women (15.3%; 95% CI 12.6-18.0%) compared to pregnant 
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women (9.9%; 95% CI 5.6-14.2%) (Table 19). Intermediate bacteria (Nugent scores 4-6) was 
also common among the population (16.1%; 95% CI 13.6-18.4%), with a higher rate among 
pregnant women (19.8%; 95% CI 14.1-25.5%) compared to non-pregnant women (15.0%; 95% 
CI 12.4-17.7). Overall, abnormal flora was present among 30.3% of the population (95% CI: 
27.3-33.3%) with similar rates between pregnant (29.7; 95% CI: 23.7-36.5) and non-pregnant 
women (27.0-33.8). 
5.4.3 Univariable analysis 
In the univariable analysis (Table 20), religion (p=0.2), recent (past 30 days) self-reported 
urinary tract infection (UTI) (p=0.2), use of tap water compared to purchased water (p=0.1) and 
age (p=0.2) all met the criteria to be considered for the final multivariable models.  
5.4.4 Adjusted Analysis 
5.4.4.1 BV Compared to normal flora 
Once adjusted  for other potential risk factors, age and recent UTI did not contribute to the 
overall model and were not included in any of the final multivariable analysis. In the 
multivariable model adjusted for religion and water source (Table 21), Muslim women were 
more likely to have BV compared to Hindu women (ORadj 1.8; 95% CI: 0.9-3.6. Women who 
reported their religion as other were not significantly more likely to have BV compared to 
Hindus (HRadj 0.63; 95% CI: 0.2-1.8). Women who used tap water were more likely to have BV 
at baseline than women who reported purchasing water (ORadj 1.4; 95% CI: 0.9-2.0). Neither of 
these increases were significant.  
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5.4.4.2 BV compared to no BV 
Comparing women with BV to those without BV, the model adjusted for religion and water 
source revealed that Muslim women were non-significantly more likely to have BV than Hindus 
(ORadj 1.7; 95% CI: 0.9-3.4). There was no difference between Hindus and the other category 
(ORadj 0.6; 95% CI: 0.2-1.9). Women who used tap water for cooking and drinking were also 
non-significantly more likely to have BV than women who used purchased water (ORadj 1.3; 
95% CI: 0.9-2.0).  
5.4.4.3 Abnormal flora compared to normal flora 
When women with abnormal flora were compared to those with normal flora, Muslim women 
(ORadj 1.5; 95% CI: 0.8-2.6) and those who used tap water (ORadj 1.2; 95% CI: 0.9-1.7) were 
more likely to have BV than Hindus and those who used purchased water, respectively. There 
was no difference between women who reported their religion as other compared to Hindus 
(ORadj 0.7; 95% CI: 0.4-1.5).  
5.5 DISCUSSION 
Though the relationship failed to reach significance, Muslim women and women who reported 
drinking tap water instead of purchased water were more likely to have BV at baseline. 
Unmeasured cultural practices, such as ritualistic bathing following menstruation and sexual 
activity,[238] may play a role in the development of BV in this population.  Women who drank 
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tap water, as opposed to purchased water, were also non-significantly more likely to have BV. 
Though our study did not collect information on what source of water women used for bathing, it 
is likely that women drinking tap water used the same source for the purpose of cleaning 
themselves. Studies of water in India have shown high percentages of coliform and other 
bacteria.[242] A handful of studies have shown that intestinal bacteria may migrate to the vagina 
and cause BV.[147-149, 172]  
Only a few studies in India have investigated potential risk factors for BV. The first, by 
Patel et al., examined a variety of reproductive tract infections (RTIs) and the influence of 
demographic variables, mainly related to socioeconomic status, among 2,495 women in a small 
community in Goa. In general, they found that women with BV were significantly more likely to 
be from outside the majority ethnicity group, to have fewer rooms in their home, to be illiterate, 
to not have access to tap water in the home, to be victims of intimate partner violence, and to 
have experienced hunger in the past three months.[124] The researchers did not take into account 
many of the behavioral factors commonly associated with BV, such as douching practices. In 
addition, this study did not show the increase in risk for those using tap water that was seen in 
our population. Women in the Goa study reported access to tap water, not whether they used it 
for drinking and cooking. Women in the LIFE study who purchase water may have access to tap 
water, but choose to use the cans instead for a variety of reasons, including knowledge of health 
risk associated with drinking tap water. Current data does not include a measure of whether 
women have access to tap water, only if they reported using it as their primary source for 
drinking and cooking The second study, by Thulkar et al, examined the association between 
recurrent vaginitis, including BV, and contraceptive use. Of the 215 women identified with BV, 
2.8% reported using either an oral contraceptive pill or a copper intrauterine device (IUD), 
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17.2% reported using condoms, 29.3% reported no contraceptive use, and 50.7% reported having 
undergone tubal ligation. [239]The sample size in the study is small and represents only women 
with a recurrent vaginitis who presented to the study hospital in New Delhi, India and does not 
have include a comparison group. In addition, no potential risk factors other than contraceptive 
devices were taken into account. Women in our study were not asked whether they were using 
any contraceptive methods other than sterilization (an exclusion criteria. Based on our initial 
pilot studies, the rates of contraceptive use in this population are negligible and likely not an 
influential factor. While contraceptive practice has shown to play a role in BV development, 
other behavioral factors may be associated with both the type of contraceptive used and BV 
infection. Further studies are needed in India and within specific Indian communities to identify 
the risk factors that are most important to the population so that public health measures can be 
targeted.  
This study has several strengths. First, we had a large, population based sample that is 
highly representative of the Medchal Mandal region of Andhra Pradesh. To our knowledge, this 
is the largest study of risk factors for BV in an Indian population. Second, compliance with our 
protocols was very high among the study population. Nearly 95% of women provided a useable 
self-collected vaginal swab at baseline. All of the enrolled women completed the registration 
questionnaire with very few missing variables.  Finally, this study used Nugent’s criteria to 
determine BV status. While this is considered the gold standard for research in the United States, 
it has rarely been used in Indian studies.  
Our study faced several limitations. First, cultural sensitivities which prevented us from 
asking more probing questions about sexual practices. Information on oral sex, anal sex, sexual 
history, number of lifetime partners, same-sex contact and extramarital sexual encounters could 
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potentially be important in this population. Second, data on potential risk factors was gathered 
through self-report. Women were asked about past vaginal infections and recent history of UTIs. 
We had no way of verifying the information provided or ascertaining what sort of infection was 
being reported. While we have no reason to believe that participants were dishonest or 
misleading interviewers on any of the questions relevant to this analysis, women may have been 
unable to accurately recall information about their behavior in the past month or may have been 
afraid to answer truthfully. This is especially true for questions pertaining to past vaginal 
infections, depressive symptoms and douching. Third, though we considered risk factors such as 
vaginal douching and recent history (past month) of a UTI, the prevalence of these risk factors in 
our study was very low and did not provide adequate power to detect a significant difference. 
Studies from a variety of populations have shown douching to be a significant risk factor for BV. 
[115, 152] In the United States, 32% of women report douching in the past month. [136] In our 
study, only 4.3% of women reported ever vaginal douching, with no information on how recently 
the woman may have douched or the frequency of the practice. A small percent of women 
(3.6%) self-reported having a UTI in the past month. This data was entirely based on self-report 
and women were not asked whether they had been diagnosed by a healthcare provider. Finally, 
while we attempted to consider all variables available in the study which may be associated with 
BV, it is possible that potentially important risk factors relevant to this population were not 
included in this analysis.  
BV is a serious vaginal infection that can cause adverse reproductive outcomes, including 
adverse pregnancy outcomes like spontaneous abortion [20, 70, 176]and preterm birth, if left 
untreated.  Since many women are asymptomatic, screening programs rely on identifying and 
targeting women at the highest risk in order to provide treatment. Development of public health 
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programs which not only help to identify potential disease, but prevent initial infection and 
recurrence requires knowledge of the most important risk factors in the population. Further 
research into other potential risk factors in the villages is necessary in order to identify 
modifiable risk factors for BV. This study identified several potential groups of individuals in the 
Medchal Mandal villages who should be targeted for screening and treatment programs. 
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5.6 TABLES 
Table 15. Baseline characteristic by BV status 
Variable All (N=898) 
  No BV  
N=771 
BV 
N=127 
p-value 
Age (mean + SD) 20.9 + 3.0 21.1 + 3.2 0.6 
Religion 
    Hindu 
    Muslim 
    Other 
  
690 (89.5) 
43 (5.6) 
38 (4.9) 
  
111 (87.4) 
12 (9.5) 
4 (3.2) 
0.2 
Caste 
    Scheduled 
    Backward 
    General 
  
  
231 (30.0) 
415 (58.8) 
125 (16.2) 
  
42 (33.1) 
63 (49.6) 
22 (17.3) 
0.7 
Health 
    Very Good/Good 
    Average/Poor                                                
  
661 (85.7) 
110 (14.3)
  
108 (85.0) 
19 (15.0) 
0.8 
Schooling 
    None 
    Primary 
    Secondary+ 
  
124 (16.1) 
474 (61.5) 
173 (22.4) 
  
  
24 (18.9) 
76 (59.8) 
27 (21.3) 
0.7 
Works away from 
home 
191 (24.8) 30 (23.6) 0.8 
Depressive 
symptoms 
44 (5.7) 8 (6.3) 0.8 
Past vaginal 
infection 
206 (26.7) 35 (27.6) 0.8 
Recent UTI 26 (3.4) 7 (5.5) 0.3 
History of douching 33 (4.3) 5 (3.9) 0.9 
Currently pregnant 173 (22.4) 19 (9.9) 0.2 
Water Source 
    Purchased  
    Tap          
  
518 (67.2) 
253 (32.8) 
 
77 (60.6) 
50 (39.4) 
0.2 
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Table 16. BV Classification by Nugent’s criteria 
 Normal1 
N (%) 
Intermediate2 
N (%) 
BV3 
N (%) 
Total 
N (%) 
N (%) 627 (69.9) 144 (16.0) 127 (14.1) 898 (100.0) 
1Scores 0-3 
2Scores 4-6 
3Scores 7-10 
 
 98 
Table 17. Results of univariable analysis 
Variable BV vs. Normal 
(Nugent 7-10 vs 0-3) 
BV vs. No BV 
(Nugent 7-10 vs 0-6) 
Abnormal vs. Normal flora 
(Nugent 4-10 vs 0-3) 
OR (95% CI) p-value1 OR (95% CI) p-value1 OR (95% CI) p-value1 
Religion 
       
Hindu 
Muslim       
Other 
  
 
Ref 
1.8 (0.9-3.6) 
0.6 (0.2-1.8)  
0.2*   
 
Ref 
1.7 (0.9-3.4) 
0.65 (0.2-1.9)  
0.2*  
 
Ref 
1.4 (0.8-2.5) 
0.7 (0.4-1.5) 
0.3 
Caste 
       
Scheduled      
Backward        
Forward 
  
 
Ref 
0.8 (0.5-1.3) 
0.9 (0.5-1.6) 
0.7   
 
Ref 
0.8 (0.6-1.3) 
1.0 (0.6-1.7) 
0.7  
 
Ref 
0.9 (0.6-1.2) 
0.8 (0.5-1.3) 
0.6 
Health Status 
       
Very 
good/Good 
       
Fair/Poor 
  
 
 
Ref 
 
1.0 (0.6-1.8) 
0.9   
 
 
Ref 
 
1.1 (0.6-1.9) 
0.8  
 
 
Ref 
 
1.0 (0.6-1.5) 
0.9 
Education 
       
None       
Primary       
Secondary+ 
  
 
Ref 
0.8 (0.5-1.4) 
0.8 (0.4-1.4) 
0.7   
 
Ref 
0.8 (0.5-1.4) 
0.8 (0.4-1.5) 
0.7  
 
Ref 
1.0 (0.7-1.4) 
0.8 (0.5-1.2) 
0.4 
Works 
outside of 
Home 
0.9 (0.6-1.4) 0.6 0.9 (0.6-1.5) 0.8 0.8 (0.6-1.2) 0.6 
Depressive 
symptoms 
1.1 (0.5-2.5) 0.8 1.1 (0.5-2.4) 0.8 1.13 (0.6-2.1) 0.7 
History of 
vaginal 
infection 
1.0 (0.7-1.5) >0.9 1.0 (0.7-1.6) 0.8 0.88 (0.6-1.2) 0.4 
Recent UTI 1.7 (0.7-4.1) 0.3 1.7 (0.7-3.9) 0.2* 1.34 (0.7-2.8) 0.4 
History of 
douching 
1.0 (0.4-2.8) >0.9 0.9 (0.4-2.4) 0.9 1.37 (0.7-2.7 0.4 
Water Source 
       
Canned 
 Tap 
  
 
Ref 
1.4 (0.9-2.0) 
  
0.1*   
 
Ref 
1.3 (0.9-2.0) 
  
0.2*  
 
Ref 
1.25 (0.9-1.7) 
0.1* 
Age  1.0 (0.9-1.1) 0.9 1.0 (0.9-1.1) 0.58 1.0 (0.9-1.1) 0.2* 
1Chi-square was used to derive p-value. Fisher’s exact test was used when cell-size was less than five 
*Considered for multivariable model 
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Table 18. Results of multivariable analysis 
  BV vs. No BV  BV vs. Normal Flora Abnormal vs. Normal Flora 
  Crude 
OR (95% CI) 
Adjusted* 
OR (95% CI) 
Crude 
OR  (95% CI) 
Adjusted* 
OR (95% CI) 
Crude  
OR (95% CI) 
Adjusted*  
OR (95% CI) 
Religion 
 
Hindu       
Muslim 
Other 
  
 
Ref 
1.7 (0.9-3.4) 
0.7 (0.2-1.9) 
  
 
Ref 
1.7 (0.9-3.4) 
0.6 (0.2-1.9) 
  
 
Ref 
1.8 (0.9-3.6) 
0.6 (0.2-1.8) 
  
  
 
Ref 
1.8 (0.9-3.6) 
0.6 (0.2-1.8) 
 
 
Ref 
1.4 (0.8-2.5) 
0.7 (0.4-1.5) 
 
 
Ref 
1.5 (0.8-2.6) 
0.7 (0.4-1.5) 
Water 
Source 
       
Canned 
Tap 
  
 
Ref 
1.3 (0.9-2.0) 
  
 
 
Ref 
1.3 (0.9-2.0) 
  
 
 
Ref 
1.4 (0.9-2.0) 
  
  
 
 
Ref 
1.4 (0.9-2.0) 
 
 
 
Ref 
1.2 (0.9-1.7) 
 
 
 
Ref 
1.2 (0.9-1.7) 
*Model adjusted for religion and water source 
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6.1 ABSTRACT 
Background: Consanguineous marriage (CM) is a common practice in South India. For couples 
looking to have children, consanguinity can result in a number of adverse pregnancy and 
neonatal outcomes. We sought to determine whether CM was a risk factor for spontaneous 
abortion (SAB) in a rural South Indian population.   
Methods: A total of 286 women between the ages of 15-35 with pregnancies identified at 
<8weeks’ gestation were included in the analysis. Cox proportional hazards regression models 
were used to estimate the association between first-cousin marriages and spontaneous abortion, 
adjusting for maternal age.   
Results: Overall, 19.9% of women reported being in a first-cousin marriage. Within the study 
population, spontaneous abortion occurred in 12.9% of pregnancies. There was a significant 
increase in the risk of early (<10 weeks’ gestation) spontaneous abortion (HRadj 2.7, 95% CI 1.1-
7.0) for women in consanguineous marriages.  Similarly, there was a trend toward increased 
risks of late spontaneous abortions (HRadj 1.2, 95% CI 0.4-3.7) or spontaneous abortions 
occurring at any gestational age (HRadj 1.9, 95% CI 0.9-3.8) among women in consanguineous 
marriages, although these associations were more modest and non-significant.   
Discussion: Our data show a significant increase in the risk for early spontaneous abortion, a 
timeframe linked with pregnancy loss due to fatal recessive disorders, among rural South Indian 
women in consanguineous marriages. Large prospective studies are needed to confirm our 
findings and determine whether they are generalizable to other populations.  
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6.2 BACKGROUND 
Consanguineous marriage (CM) is defined as the union between two individuals who are related 
as second cousins or closer. [27] Globally, the prevalence of CM varies greatly. In developed 
countries like the United States, Western Europe, and Australia, rates are as low as 5%. [204] 
Much higher rates are seen in the Middle East, where studies have reported populations with CM 
prevalence rates of nearly 70%. [243] In India, rates differ depending on the geographic region 
within the country. The northern states have CM rates of between one and ten percent, while the 
southern states have rates between 20-60%. [27] The state of Andhra Pradesh has one of the 
highest rates in India, with 46% of women reporting being in a related marriage. [21] Globally, 
and in India, first cousin marriages are the most common form of consanguineous relationships, 
comprising roughly 20-30%. [204] 
Marriage between related individuals has been shown to result in a number of adverse 
outcomes among offspring. Several studies point toward an increased risk of death among the 
offspring of consanguineous couples, with excess death rates up to 1.5%. [22, 23] The most 
commonly studied and well known association with CM is congenital anomalies. Offspring of 
related individuals are more likely to have uncommon autosomal recessive conditions that are 
rarely seen in the offspring of non-consanguineous couples. [26, 204] Depending on the 
population and condition, the risk is generally considered to be 1.7-2.8% higher for the children 
of first cousins than for those from non-related couples.  
CM may also result in SAB, [226, 230, 233] although the epidemiologic study of SAB is 
methodologically challenging. Early miscarriages often occur before women are aware of the 
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pregnancy, making it difficult to rely on self-report or even clinical studies to determine the true 
rate. Chromosomal abnormalities are implicated in roughly 50% of early losses. [209] Sources 
have shown that the SAB rate is generally 15-20% of pregnancies, but this number may be as 
high as 50% if pre-clinical losses are included. [208, 209] In developing countries, where the 
majority of CMs occur, studies are even more difficult to conduct due to lack of health care 
infrastructure. For this reason, most studies looking at the association between CM and 
spontaneous abortion have been cross-sectional in nature and derived from survey data. Many of 
these studies have shown significant associations, [226, 230, 233] but other have had null results. 
[228, 229, 231, 232] Differences in rates and outcomes may differ within populations as a result 
of the amount of related marriage that has taken place over the years.  
Our study took an active role in identifying early pregnancies as well as spontaneous 
abortions, providing data on SABs that might be missed using cross-sectional and self-report 
data. In addition, southern India, especially the state of Andhra Pradesh, is understudied in terms 
of both consanguineous marriage and birth outcomes. As populations, even within India, can 
vary greatly in terms of these variables, studies are needed to determine whether there is an 
increased burden in this region and to provide proper guidance for medical professionals and 
women looking to conceive. This paper aims to look at the association between first cousin 
marriages and spontaneous abortion in this area.  
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6.3 METHODS 
6.3.1 Study Population 
The Longitudinal Indian Family hEalth (LIFE) study is a prospective cohort of 1,226 
childbearing age women from Medchal Mandal, a rural area outside Hyderabad, India. Women 
ages 15 to 35 were eligible to participate in the study if they lived in one of the non-transient 
villages in Medchal Mandal, planned to have more children, were not pregnant beyond the first 
trimester, and neither the woman nor her husband had undergone a sterilization procedure. 
Husbands of participating women were encouraged to enroll in the study. Demographic 
variables, health status, behavioral factors and environmental exposures were ascertained using 
questionnaires at enrollment. Women also provided urine, stool, blood and vaginal swab samples 
for analysis. Repeat questionnaires and biological samples were collected at the beginning of the 
first trimester, beginning of the third trimester, delivery and 28 days post-partum. Women 
identified as pregnant at enrollment were administered both registration and first trimester 
questionnaires, but provided only one set of biological samples for the two time points. 
Field staff called or visited enrolled women monthly to determine the most recent date of 
the participant’s last menstrual period (LMP). Women found to be more than five weeks post-
LMP were provided with a urine pregnancy test.  Throughout the first and second trimester, 
women were monitored for losses. At ten and twenty weeks’ gestation, a field worker visited the 
woman to discuss her plans for the pregnancy and delivery and to perform a urine pregnancy test 
as confirmation of a progressing pregnancy. Women also reported known losses to field staff 
members. A pregnancy loss questionnaire was administered to all women who had a pregnancy 
that ended in anything other than a live birth.  
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This analysis was limited to women who had contributed at least one pregnancy to the 
study, had a singleton pregnancy, had either had a spontaneous abortion or had a pregnancy that 
was confirmed to be continuing past 22 weeks’ gestation as ascertained at the third trimester 
visit. For women who had contributed more than one pregnancy to the study, only the first was 
used. Women who had ectopic pregnancies or induced abortions were excluded. To maximize 
the number of pregnancy losses identified, analyses were limited to women who had pregnancies 
identified at <10 weeks’ gestation. 
6.3.2 Related Marriage Definition 
Women were asked at enrollment whether they were related to their husband prior to marriage. 
Those who answered in the affirmative were then asked to identify the nature of the relationship 
based on a provided list of common consanguineous relationships. Women who identified 
relationships that did not meet the standard definition of a consanguineous marriage or who were 
unable to provide information on the relationship were excluded. Participants who reported being 
in a related marriage almost exclusively reported being in a first-cousin marriage; therefore, the 
analysis was limited to those in non-consanguineous marriages and those in first-cousin 
marriages. 
6.3.3 Spontaneous Abortion Definition 
Spontaneous abortion was defined as a spontaneous loss occurring at <22 weeks’ gestation. Last 
reported LMP was used to determine gestational age in the study. At the time of a loss, women 
were asked to estimate the date on which the loss occurred. If they were unable to pinpoint a 
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date, participants were prompted to approximate based on the last date that the study staff were 
sure the woman was pregnant. Spontaneous abortions were then classified as having occurred 
early (<10 weeks’ gestation) or late (11 to 22 weeks’ gestation). 
6.3.4 Statistical Analysis 
Analyses were performed using STATA 12.0 statistical software. [240] Maternal characteristics 
were compared between those in related and unrelated marriages using the Student t-test for 
continuous variables and the chi-square test of proportions for categorical variables. In the case 
of low expected cell counts, Fisher’s exact test was substituted for the chi-square test. We used 
Cox proportional hazards survival models to characterize the rate of spontaneous abortion for 
those in first-cousin marriages compared to those in unrelated marriages. Left truncation was 
used to account for variability in the gestational age at which the pregnancy was identified. 
Potential confounders included woman’s age at the time of pregnancy, caste, self-reported health 
status at first trimester, educational level, parity, gravidity, and religion. Risk factors that had a p-
value <0.25 from the univariable analysis were considered for inclusion in the final model.  
Additional analyses were performed to examine the risk of early spontaneous abortion (<10 
weeks’ gestation) and risk of later spontaneous abortion (10-22 weeks’ gestation).  
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6.4 RESULTS  
This study included 286 women who enrolled in the study and became pregnant between August 
2009 and July 2011 (Table 1). Fifty-seven women (19.9%) reported being in first-cousin 
marriage. Overall, the mean age of the study population was 21.6 years. The majority  of the 
sample was Hindu (88.8%), had a primary school education (61.5%), belonged to a backward 
caste (56.3%), reported their health status at the first trimester as either very good or good 
(87.1%), had at least one prior pregnancy (65.7%) and at least one prior live birth (60.1%). 
Pregnancies in this analysis were identified at a mean gestational age of six weeks. There were 
no significant differences between the characteristics of the women in unrelated marriages 
compared to those in first-cousin marriages.  
Among the women in the sample, 37 (12.9%) had a spontaneous abortion, with 26 
(11.4%) occurring among women in non-consanguineous relationships and 11 (19.3%) among 
women in first-cousin relationships (Table 2). Losses were split almost equally between the early 
spontaneous abortions (n=19) and late spontaneous abortions (n=18). Women in first-cousin 
marriages had a higher percentage of their spontaneous abortions in the early period (63.0%) 
compared to women in non-related marriages (46.2%).  
Of the potential confounding factors investigated, only maternal age at the time of 
pregnancy met the criteria to be included in the final model. In the unadjusted analysis, women 
in first-cousin marriages were at an insignificant increased risk of spontaneous abortion 
compared to women in non-related marriages (HR 1.8, 95% CI 0.9-3.6) (Table 3). The risk 
remained non-significant once adjusted for maternal age (HRadj 1.9, 95% CI 0.9-3.8). Unadjusted 
analyses of early spontaneous abortion showed an insignificant increase in the risk of 
spontaneous abortion among women in first-cousin marriage (HR 2.5, 95% CI 1.0-6.2).  
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However, this risk became significant once adjusted for maternal age (HRadj 2.7, 95% CI 1.1-
7.0). No significant increase was seen for late spontaneous abortion (HR 1.2, 95% CI 0.4-3.7; 
HRadj 1.2, 95% CI 0.4-3.7). 
6.5 DISCUSSION 
Consanguineous marriage is common in many parts of the world, including South India. Our 
results showed a significant increase in the risk of early spontaneous abortion among women in 
consanguineous versus unrelated marriage, after accounting for maternal age. Similar trends 
were observed for late spontaneous abortions among women in consanguineous marriages, but 
these risks were modest and not statistically significant. This pattern is likely to reflect the lethal 
homozygous recessive conditions that may lead to early spontaneous abortion.[231] 
Other studies on the risk of spontaneous abortion among consanguineous couples in India 
have shown mixed results. A study of a population in Tamil Nadu showed a significant increase 
in SAB [233], while others conducted in various regions of South India, excluding Andhra 
Pradesh, have shown insignificant [229, 231, 232] or mixed results. [230] As all of these studies 
have relied on retrospective data on spontaneous abortion self-reported by mothers, the studies 
may have missed capturing early spontaneous abortions that might go unnoticed in non-planning 
populations with little access to healthcare. Further, due to the nature of the studies, they were 
unable to separate out early and late spontaneous abortions. In addition, different geographical 
and ethnic groups in India have different marriage customs and may have different levels of 
overall relatedness. The effects of consanguineous marriage within one region may not be 
indicative of the risk in another as the overall relatedness of a given community influences the 
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prevalence of adverse conditions and outcomes. The results of this study along with previous 
research demonstrate a need for larger prospective studies that able to identify early pregnancies 
and losses among a variety of populations.  
To our knowledge, this is the first study in Andhra Pradesh to prospectively look at the 
relationship between consanguineous marriage and spontaneous abortion. Despite the high rate 
of consanguineous marriage in Andhra Pradesh, little information on the degree of relatedness of 
couples in the area and the impact on offspring exist. Most studies of consanguineous marriage 
and pregnancy outcomes, including those done in other parts of India, have relied on self-
reported data on past pregnancy losses collected during surveys. Our prospective design allowed 
us to enroll women pre-pregnancy and follow them in order to identify pregnancies, and thus 
pregnancy losses, early than would have been possible in pre-natal clinics.  
This study had several limitations. First, despite active monitoring of women, only about 
a third of women had pregnancies identified at <8 weeks’ gestation, and thus were eligible to be 
included in this analysis. Second, women were asked to self-report their pre-marital relationship 
to their husband. No information on ancestral relationship between the couple was available in 
this study. Some couples may be more related than the current analysis allows for. Future studies 
using blood samples may be able to determine the true degree of relatedness among participants.  
Finally, there may be misclassification of the outcome variable. Spontaneous abortions were 
ascertained through staff follow-up and self-report. It may have been several days or weeks 
between when the actual loss occurred and when the women became aware of the loss. For those 
who were near the cutoff of 22 weeks’ gestation, they may have been misclassified as having had 
a stillbirth. To determine whether this was a potential problem in our analysis, a single fetal 
death variable consisting of both SABs and stillbirths (n=36) was used to repeat the analysis. 
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Overall, this change had little impact on our estimates and did not change the conclusion. In 
addition, while staff attempted to identify pregnancies as early as possible in order to have the 
greatest chance of observing any losses that occurred, there was still a period of time between 
conception and confirmation of pregnancy where some preclinical losses likely occurred.  
While India, particularly the southern states, has a high rate of consanguineous marriage, 
little is known about the potential relationship between related marriage and spontaneous 
abortion. Our study showed that early spontaneous abortions were statistically more likely to 
occur among women in first-cousin marriages than among women in non-consanguineous 
marriages. Information on risk of spontaneous abortion, especially with regard to timing of 
losses, may help health care providers to better counsel patients who are having trouble 
conceiving or are having recurrent miscarriages. More prospective studies in a variety of regions 
and ethnic groups are needed to replicate this finding.  
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6.6 TABLES 
Table 19. Baseline characteristic by related marriage status 
Variable Overall 
(n=286) 
Unrelated 
Marriage 
(n=229) 
First-Cousin 
Marriage 
(n=57) 
p-value 
Age at pregnancy 21.6 21.7 21.3 0.3 
Religion 
    Hindu 
    Muslim 
    Other 
 
254 (88.8) 
17 (5.9) 
15 (5.2) 
 
204 (89.08) 
14 (6.11) 
11 (4.80) 
 
50 (87.7) 
3 (5.3) 
4 (7.0) 
0.7 
Education 
    None 
    Primary 
    Secondary+ 
 
43 (15.0) 
176 (61.5) 
67 (23.4) 
 
36 (15.7) 
138 (60.3) 
55 (24.0) 
 
7 (12.3) 
38 (66.7) 
12 (21.1) 
0.7 
Caste 
    Scheduled Tribe/Caste 
    Backward Caste 
    Other 
 
87 (30.4) 
161 (56.3) 
38 (13.3) 
 
65 (28.4) 
134 (58.5) 
30 (13.1) 
 
22 (38.6) 
27 (47.4) 
8 (14.0) 
0.3 
Health Status 
    Very Good/Good 
    Average/Poor 
 
249 (87.1) 
37 (12.9) 
 
197 (86.03) 
32 (13.97) 
 
52 (91.2) 
5 (8.8) 
0.4 
Previous  pregnancies 
    None 
    1 
    2+ 
 
98 (34.3) 
123 (43.0) 
65 (22.7) 
 
81 (35.4) 
98 (42.8) 
50 (21.8) 
 
17 (29.8) 
25 (43.9) 
15 (26.3) 
0.7 
Previous births 
    None 
    1 
    2+ 
 
114 (39.9) 
137 (47.9) 
35 (12.2) 
 
89 (38.9) 
112 (48.9) 
28 (12.2) 
 
25 (43.9) 
25 (43.9) 
7 (12.3) 
0.8 
Gestational age at time of 
pregnancy ascertainment 
(weeks) 
6.0 6.0 6.1 0.6 
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Table 20. Cox regression models: First cousin marriage and spontaneous abortion 
 
 Unadjusted HR (95% CI) Adjusted HR* (95% CI) 
Any spontaneous 
abortion 
1.7 (0.9-3.6) 1.9 (0.9-3.8) 
Early spontaneous 
abortion1 
2.5 (1.0-6.2) 
 
2.7 (1.1-7.0) 
Late spontaneous 
abortion2 
1.2 (0.4-3.7) 1.22 (0.4-3.7) 
*Model adjusted for maternal age at the time of pregnancy 
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7.0  CONCLUSIONS AND PUBLIC HEALTH SIGNIFICANCE 
The World Health Organization (WHO) estimates that 20% of the burden of disease among 
women is related to sexual and reproductive health. [244] In developing countries, access to 
screening, treatment and information can be scarce or non-existent, especially in rural areas. 
Though many STIs and RTIs are curable with antibiotic treatment, failure to identify these 
conditions early and provide adequate care can lead to serious adverse outcomes, including PID, 
infertility, increased risk of other infections, SAB, PTB and birth of a LBW infant. 
Though much research has been done to determine risk and protective factors for RTIs 
like BV, this work has mainly been done in Western countries, like the United States. While this 
research allows for the greatest access to laboratory and healthcare infrastructure, it does not 
include the people who are often at the greatest risk of complications from infection. Our study 
sought to look at unique factors in an Indian population that might play a key role in screening 
and diagnosis of BV. 
Proper diagnosis of BV requires adherence to strict clinical or laboratory guidelines. In 
underdeveloped regions, like rural Andhra Pradesh, individuals trained in these methods are 
often not available. Suitable alternative that are relatively fast, easy to use and accurate are 
needed in order to effectively screen a large number of women. Use of clue cell analysis has 
been proposed as an alternative to Nugent’s laboratory criteria or Amsel’s clinical criteria. 
However, this method had not previously been fully assessed for accuracy. In our comparison of 
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clue cell analysis to Nugent’s criteria we found that while clue cells were able to accurately 
identify women without BV 81.2% of the time, it only correctly identified cases 39.8% of the 
time. As a result, we recommend that future studies be conducted to determine whether single 
criterion from Amsel’s diagnostic criteria, such as increased vaginal pH levels or a positive whiff 
test, might provide better sensitivity.  
Proper screening and diagnosis of large groups of people, especially in cases like BV 
where the majority of women are asymptomatic, can be time and resource intensive. 
Identification of women who are at higher risk can help to target public health programs on the 
individuals most likely to benefit from them. Though many studies have previously examined 
potential risk factors for bacterial vaginosis, they have often focused on population in the United 
States and Europe. As behavioral, cultural and environmental factors may all play a role in the 
development of BV, we sought to determine what variables might be important within a rural 
India population. No significant factors related to increased risk of BV at baseline were 
identified. However, religion and water source were borderline significant. These variables may 
be surrogates for unmeasured cultural practices and behavior and will be considered for future 
analysis.  
Finally, we were interested in looking at the effect of consanguinity, specifically first 
cousin relationships, on spontaneous abortion. Nearly a quarter of the study population reported 
being married to someone they were related to prior to marriage, representing a significant 
portion of our participants. In an analysis adjusted for maternal age at pregnancy, we found that 
women in first cousin marriages were at a significantly increased risk for an early (<11 weeks’ 
gestation) spontaneous abortion. This is hypothesized to be related to recessive genes that 
prevent the fetus from adapting to intrauterine life. Knowledge of risk factors can provide 
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valuable information to pregnant women and those seeking to become pregnant, as well as to the 
providers who counsel and provide care to these women. 
As the LIFE study is an ongoing project, the valuable knowledge gained in these 
investigations will help to inform future research an analysis. PCR for detection of specific BV-
related bacteria is planned for the near future and will be combined with the Nugent scores to 
provide a clearer picture of the characteristics of BV in the population. In addition to looking at 
what risk factors may be associated with these specific bacteria, we plan to look at pregnancy 
outcomes, such as preterm birth, spontaneous abortion, low birth weight and intrauterine growth 
restriction that may be associated with BV. Studies to look at factors related to spontaneous 
abortion are also planned and will use consanguinity as a potential confounder in the analysis.  
Reproductive health combined with maternal and child health are important to the 
ongoing wellness of a community. In areas such as India where public health resources are 
scares, identification of factors that increase the risk of disease and adverse outcomes provides 
screening programs with the information necessary to target the groups of people who are at the 
greatest need. Further, public health interventions can be planned around modifiable risk factors 
in order to decrease the incidence of conditions within the community. These studies are first 
step to identifying risk and protective factors that are at play with this rural Indian community. 
Future studies will build upon the work presented here and develop a body of knowledge that can 
be drawn upon for future programs.  
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APPENDIX A 
LIFE STUDY WOMEN’S REGISTRATION QUESTIONNAIRE 
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APPENDIX B 
LIFE STUDY FIRST TRIMESTER QUESTIONNAIRE 
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APPENDIX C 
LIFE STUDY PREGNANCY LOSS QUESTIONNAIRE
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